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1. LIST OF ABBREVIATIONS 
 
AK-cyclo[RGDfC] – peptide polymer with cyclic arginyl-glycyl-aspartic acid motifs 
APTES  – 3-aminopropyltriethoxysilane 
BSA   – bovine serum albumin 
BV2   – mouse microglial cell line 
CPI   – Nanotechnology Consumer Product Inventory 
CX3CR1  – CX3C chemokine receptor 1 or fractalkine receptor 1 
DAPI   – 4',6-diamidino-2-phenylindole, nuclear staining 
DLS   – dynamic light scattering 
DMEM  – Dulbecco's modified Eagle's cell culture medium 
EGF   – epidermal growth factor 
F12   – Ham’s F12 nutrient mixture 
FCS   – fetal calf serum 
FITC   – fluorescein-isothiocyanate 
GFAP   – glial fibrillary acidic protein 
Iba-1   – ionized calcium-binding adapter molecule 1  
ITS   – insulin, transferrin and selenium solution 
LDH assay  – lactate dehydrogenase release assay 
M   – molecular weight marker in SDS-PAGE analysis 
MEM   – minimum essential medium 
MEM-F12-ITS – 1:1 mixture of MEM:F12 supplemented with 1 % ITS 
MEM-F12-B27 – 1:1 mixture of MEM:F12 supplemented with 1 % B27 
MPTMS  – 3-mercaptopropyltrimethoxysilane 
MRI    – magnetic resonance imaging 
MTT assay  – colorimetric assay for assessing cell metabolic activity 
NE-4C  – mouse neuroectodermal stem cell line 
NIR   – near-infrared 
NP   – nanoparticles 
p53   – cellular tumor suppressor protein p53 
PBS   – phosphate buffered saline 
PEG   – polyethylene glycol 
PET   – positron emission tomography 
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PFA   – paraformaldehyde 
PLL   – poly-L-lysine 
PS-NP   – polystyrene nanoparticles 
PS-COOH  – carboxylated polystyrene nanoparticles 
PS-PEG  – PEGylated polystyrene nanoparticles 
PVP   – polyvinylpyrrolidone 
RA   – all-trans retinoic acid 
ROI   – region of interest 
SD   – spectral detector 
SDS-PAGE  – sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEM   – scanning electron microscopy 
SiO2-NH2  – amino-modified silica nanoparticles 
SiO2-NP  – silica nanoparticles 
SiO2-PVP  – PVP-coated silica nanoparticles 
SiO2-SH  – mercapto-modified silica nanoparticles 
SPECT  – single photon emission computed tomography 
SR   – spectral ratio 
TEM   – transmission electron microscopy 
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2. INTRODUCTION 
2.1. Nanomaterials and nanoparticles 
Nanomaterials are usually categorized as structured components with at least one 
dimension in the 1-100 nm range (ISO/TS 80004-1:2015, (ISO 2015)). Within the broad 
definition, nanostructured materials can be classified according to their internal or surface 
structures in the nanoscale, or, in case of nano-objects, according to their “external” 
dimensions in the 1-100 nm range. Nano-objects, with one dimension in the sub-micron 
range are layers, such as graphene or thin films; materials with two dimensions in the 
nanoscale include nanofibers. My thesis work was focused on nanoparticles (NP), which 
have three external dimensions in the nanoscale (Figure 1; (ISO 2015)). 
 
Figure 1: Hierarchy of nanomaterials 
Nanomaterials can be classified into several categories based on their external or internal 
dimensions in the nanometer range. 
While nanotechnology is a new and rapidly growing field that cuts across an array of 
industrial and scientific sectors, the coexistence with and the use of nanoparticles has a 
long history. In stained glass and pottery gold nanoparticles had been used for centuries 
as inorganic dyes to create red color (Cao and Wang 2004). Nanoparticles are inherent 
components of the nature as well. Natural nanoparticles exist in the environment, as the 
products of biological decay, forest fires and volcanic activity, they occur naturally in 
ocean spray, fine sand or even cosmic dust (Strambeanu et al. 2015) and can be created 
by plants and bacteria (Lin et al. 2014). NPs are generated by human activity as incidental 
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by-products of combustion or even food cooking, and more recently, as derivatives of 
vehicle exhausts of car or airplane engines. Engineered nanoparticles, which facilitate the 
most dramatic technological advances, are novel products of human activity and are 
produced in rapidly growing quantities all over the World. 
2.2. Properties of nanoparticles 
Regarding physicochemical characteristics, nanoparticles lay between molecular 
structures and bulk materials. Materials with known properties in the bulk form can exert 
new characteristics in the nanoscale range. The unique characteristics of NPs arise from 
the small size and their consequent high surface-to-volume ratio. Compared to bulk 
material, a much larger proportion of atoms are surface-exposed atoms in nanoparticles. 
Figure 2 shows, how the percentage of the surface atoms changes with the cluster 
diameter for palladium. When the  particles  change  from centimeter  size  to  nanometer  
size,  the  surface  area  and  the  surface energy increase seven orders of magnitude (Cao 
and Wang 2004). 
 
Figure 2: The percentage of surface atoms changes with the palladium cluster 
diameter 
The total number of surface exposed atoms increases with the decrease of the cluster 
diameter, which in turn will strongly effect the overall surface energy. (C. Nützenadel 
2000) 
Surface atoms have fewer neighbors, thus are prone to less cohesive energy and higher 
chemical reactivity. The resulting huge surface energy creates unique mechanical, 
electrical, thermodynamical properties, changes the catalytic activity of NPs and makes 
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NPs advantageous for various applications. The increased activity makes NPs more prone 
to reactions with the environment and also with each other, which can result in formation 
of homo- and hetero-agglomerates. One of the great  challenges  in  fabrication  and  
processing  of nanomaterials is to overcome the surface energy, and to prevent the growth 
in size, driven by the natural force to reduce the overall surface energy (Cao and Wang 
2004). In parallel with the surface-effects, quantum mechanical properties of materials 
are also altered in the nanometer range. The energy-states of electrons are relatively easily 
modified in nanoparticles, leading to characteristic semiconductor, magnetic and optical 
behaviour (e.g. surface plasmon resonance, or particle size dependent color and emitted 
light) (Roduner 2006). 
The unique physicochemical properties that make NPs attractive for pioneering research, 
however, may bring potential health hazards. Regarding the increased production, the 
widespread industrial, medical and domestic applications, the enhanced presence of 
engineered NPs in our surrounding raises serious questions concerning their interaction 
with biological systems.  
2.3. Health risks of NP production and application 
2.3.1. Use of nanoparticles in consumer products 
Many authorities predict that applications of nanotechnologies will pervade all areas of 
life and will enable dramatic advances (ISO 2015). According to the Nanotechnology 
Consumer Product Inventory (CPI, http://www.nanotechproject.org) the number of 
products containing NPs is continuously increasing (Figure 3). 
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Figure 3: Number of consumer products containing nanoparticles 
The number of NP-containing consumer products, increased ~30-fold from 2005 to 2013. 
(http://www.nanotechproject.org) 
Nanomaterials are widely used in various consumer goods, from electronics and wall 
paint to clothing, food and personal care products (e.g. cosmetics and sunscreens). Nano-
additives are usually used  to improve handling, stability and efficacy of the products 
(Vance et al. 2015). 
In nanomedicine nanoparticles may find application in drug delivery, bio-imaging, 
diagnostics and therapeutics. NPs can modify the kinetics, body distribution and drug 
release of an associated drug. A famous example of NP-mediated drug delivery is the 
anti-cancer nanoliposomal doxorubicin (Doxil®), the first FDA-approved nano-drug, 
which can "passively target" and attack tumors due to the enhanced penetration of 
nanoliposomes and the retention of encapsulated doxorubicin (Barenholz 2012). 
Furthermore, several NP-based bio-imaging techniques are used or are under 
development. NP probes have been used in conjunction with magnetic resonance imaging 
(MRI), positron emission tomography (PET), single photon emission computed 
tomography (SPECT), and near-infrared (NIR) fluorescence imaging (Geng et al. 2014, 
Leary and Key 2014, Bouccara et al. 2015). Given the high performance of nanostructure-
based NP-probes, application in human subjects is appealing (Hu et al. 2010). Prior to 
clinical application, however, a comprehensive understanding of the biological effects of 
diverse types of NPs is essential including toxicity, biodistribution and pharmacokinetics. 
DOI:10.14753/SE.2017.2019
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2.3.2. Health risks of NPs 
Developments in nanomedicine aim to improve efficacy of NPs by increasing specific 
cellular uptake and tissue permeation (Chen et al. 2014), whereas consumers and factory 
workers should be protected against non-intended exposure and uptake of nanoparticles. 
While early and intensive efforts have been made to study the toxicity of various NPs, 
keeping pace with the fast development of nanotechnology is challenging nanosafety 
measures. For testing the safety of nanoparticles researchers, regulators and protection 
agencies should posess fast and reliable measurement systems and evaluation protocols 
supported by robust standards (ISO 2015). 
To facilitate hazard assessment of NPs several classification approaches have been 
proposed. NPs can be classified into categories based on the similarities in their 
physicochemical properties and their biological effects. Testing according to the category 
requirements, can reduce the number of case-by-case evaluation (Gebel et al. 2014). In 
contrast to fibrous nanomaterials (Champion and Mitragotri 2006), the shape of spherical 
nanoparticles is not considered as an immediate hazard. The major mode of action in case 
of spherical NPs is chemically mediated toxicity. The adverse effects may originate from 
(1) the release of toxicants from NPs, usually ions, (2) the reactions of active surface 
groups and (3) the catalytic activity of NP surfaces (Gebel et al. 2014). 
2.4. NPs with non-toxic core materials 
Nanoparticles, and especially non-metal nanoparticles, are widely used in biomedical 
applications because of the biologically inert or biosimilar properties. From the variety of 
NPs with non-toxic core material, the properties of two widely produced and applied NPs 
are presented. 
2.4.1. Polystyrene nanoparticles 
Polystyrene (PS) is a nontoxic and not carcinogenic polymer. Due to its inertness and 
biocompatibility, polystyrene is widely used for the production of biomedical devices and 
laboratory equipment. It is a well characterized  and extensively used polymer, with many 
applications in the everyday life (European Commission Risk Assessment Report 2002). 
In the present EU regulation, both styrene and polystyrene are listed without any 
restriction to come into contact with food (EU 2008). Consumers are continuously 
exposed to polystyrene and low-dose styrene residues from food-packaging. REACH 
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(Registration, Evaluation, Authorisation and Restriction of Chemicals) regulation 
established a “derived no effect level” for long-term, oral route exposure in the general 
population, which was 2.1 mg/kg bodyweight /day for styrene (Gelbke et al. 2014). 
Polystyrene does not degrade in the cellular environment and exhibits no short-term 
cytotoxicity, facilitating its use in food and medical products. On the other hand, styrene’s 
elimination is slow and it can be bio-transformed into styrene-7,8-oxide in the liver and 
excreted as catabolites (Filser and Gelbke 2016). 
Polystyrene nanoparticles are commercially available in plain or in fluorescently labelled 
forms, synthetized in various sizes with diverse surface functional groups. Such particles 
are used in many applications, including diagnostic tests, flow cytometry, fluorescent 
microscopy and as calibration particle standards. 
Despite of the non-toxic nature of bulk polystyrene and styrene, several recent data 
indicated mild toxicity of PS nanoparticles (Lunov et al. 2011, Fröhlich et al. 2012, 
Mahler et al. 2012, Paget et al. 2015). Experimental data indicated that the cytotoxic 
effects were mediated by surface functional groups and not by the core material. In 
general, positively charged PS-NPs with cationic functional groups, showed higher 
cytotoxicity compared to negatively charged or neutral particles (Hardy et al. 2012, Paget 
et al. 2015, Ruenraroengsak and Tetley 2015). The mild or non-toxic properties allowed 
us to use polystyrene NPs for studying the effects of surface functionalization on the 
interactions of NPs with biological material. 
2.4.2. Silica nanoparticles 
The term silica, refers to naturally occurring or anthropogenic materials composed of 
silicon dioxide (SiO2), which appear in two major forms, i.e., crystalline and amorphous. 
Crystalline silica is most commonly found in nature as quartz, and is a basic component 
of soil, sand, granite, and many other minerals, as well as glass. While silica is regarded 
generally as a non-toxic chemical, occupational exposure to crystalline silica dust (for 
example in case of construction and mine workers) was associated with an increased risk 
for pulmonary diseases such as silicosis, tuberculosis, chronic bronchitis, and lung cancer 
(Merget et al. 2002). 
In contrast to crystalline silica, amorphous silica particles have been approved for oral 
administration for decades and are registered by the EU as a food additive with code E551 
(OECD 2016). Synthetic amorphous silica is widely applied in processed foods, it is 
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added to prevent caking, poor flow, to control foaming, to clarify beverages or to carry 
flavors (EU 2011). 
In medical applications amorphous silica nanoparticles have attracted significant interest 
as promising candidates for drug delivery systems (Garcia-Bennett 2011, Tang and Cheng 
2013), imaging or diagnostic tools and anti-cancer therapeutics (Hirsch et al. 2003). For 
example, ultrasmall nonporous silica NPs were already approved for human clinical trial 
by the FDA for exploring targeted molecular imaging of tumors (Benezra et al. 2011, 
Bradbury et al. 2013). 
As potential drug delivery vehicles, amorphous silica nanoparticles were shown to carry 
sufficient drug loads, efficiently cross physiological barriers to reach target sites 
(Baghirov et al. 2016, Mo et al. 2016). Further favorable properties of amorphous silica 
nanoparticles include good biocompatibility (Lu et al. 2010), versatile silane-chemistry 
for surface functionalization and tailoring of surface reactivity (Walcarius and Ganesan 
2006), the ease of large-scale synthesis and the low cost of NP production. 
Despite of the favorable properties and the potential medical applications, important 
questions were raised regarding the biosafety of amorphous silica particles. Sound 
evidence of safety is still missing, and relevant risk assessment has never been 
satisfactorily completed (Winkler et al. 2016). 
2.5. Protein corona 
The biological identity of NPs can be altered by interactions with the physiological 
environment, through the formation of a biomolecular corona. The biomolecular corona 
is composed by several layers of compounds adsorbed from the actual environment. 
Particles can act by a ‘Trojan horse mechanism’, as chemicals bound to particle surfaces 
may be taken up by cells more efficiently. After particle uptake, the solubility and 
bioavailability of internalized compounds may increase due to the lower pH in 
phagolysosomes. This mechanism can enhance toxicity compared to the standard bulk 
material (Gebel et al. 2014). 
2.5.1. Protein corona formation on NP surfaces 
NPs readily adsorb various chemical substances from their environments due to the highly 
reactive surface (Monopoli et al. 2012). Unless they are specifically designed to avoid it, 
NPs in contact with biological fluids are rapidly covered by a selected group of 
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biomolecules. The biomolecules on NP surfaces form the so-called protein corona that 
masks the “bare” NP-surface (Figure 4). Since the original surface of the particle is no 
longer “visible” to the cells, the corona governs the interactions of NPs with biological 
structures and plays a decisive role in the tissue- and cell-type-specific NP distribution 
(Monopoli et al. 2012, Salvati et al. 2013, Tenzer et al. 2013). 
 
Figure 4: Formation of nanoparticle corona: In contact with biological fluids proteins 
and biomolecules adhere to “bare” nanoparticles. The surrounding layer around NP-
surfaces is the so-called protein corona. (Elsaesser and Howard 2012) 
The protein corona is changing dynamically over time. The composition and thickness of 
the adsorbed layers depends on the chemical properties of both the NP surface and the 
environment (Casals et al. 2010, Lundqvist et al. 2011, Casals and Puntes 2012). The 
“soft corona” that forms initially, consists of high-abundance and/or high-mobility 
proteins. Over time, the weakly bound, low-affinity proteins are replaced by high-affinity, 
tightly bound proteins that comprise the “hard corona” (Figure 5) (Fleischer and Payne 
2014). The initial adsorption is mediated by protein-nanoparticle binding affinities, while 
later, protein-protein interactions play a role as well.  
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Figure 5: Schematic representation of protein corona formation on a nanoparticle 
surface 
Protein adsorption is a kinetic (k) and thermodynamic (K) function of both the individual 
proteins and NP properties. Initially, high-abundance and/or high-mobility proteins bind 
to the nanoparticle surface, which are replaced gradually by proteins with lower-mobility 
but higher binding affinity. Serum proteins commonly observed in NP coronas are shown 
as a representative corona: serum albumin, immunoglobulin G1 (IgG1), alpha-2 
macroglobulin (A2M), and apolipoprotein A-1 (apoA1) (Fleischer and Payne 2014). 
It has to be noted, that while the majority of biomolecules adsorbed from blood plasma 
are proteins, some minor traces of lipids have also been reported (Hellstrand et al. 2009). 
The composition of the evolving protein corona is affected by various parameters. 
Physical and chemical properties of the nanoparticles, including size, shape, curvature, 
composition, surface charge (zeta-potential) and surface modifications play important 
role, just as the properties of the surrounding environment (Lundqvist et al. 2008). As a 
result of chemical exchange reactions, the corona is expected to change with time even 
within the same tissue environment (Casals et al. 2010, Casals and Puntes 2012, Milani 
et al. 2012), however, if particles are transferred to a new environment, significant 
evolution of the corona occurs and the final corona will contain the print of the NP’s 
history (Lundqvist et al. 2011). 
2.5.2. Effects of surface functional groups on corona formation 
While NP surfaces are ultimately functionalized by the actual environment, this process 
can be regulated by changing the charge and chemical composition of NP surfaces. Via 
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functional groups, nanoparticles can gain activated or passivated surfaces, which attract 
or repel inorganic, organic and biological macromolecules, resulting particles with novel 
reactivity and consequently, absorbed bio-molecules with altered activity (Wang et al. 
2011). By coating the NPs with specific functional groups, NPs can target certain cells or 
tissues (Mahon et al. 2012), or if coated with biologically inert substances, as hydrophilic 
polymers (Izak-Nau et al. 2013b, Sacchetti et al. 2013) they can avoid particular unwanted 
interactions. 
Polyvinylpyrrolidone (PVP) and polyethylene glycol (PEG) polymers with different 
oligomer-numbers and linear or branching chains have been widely used to reduce the 
chemical reactivity of surfaces (Izak-Nau et al. 2013a, Sacchetti et al. 2013). Accordingly, 
protein adsorption and cellular uptake of NPs could be reduced by PEGylation and PVP-
coating (Peracchia et al. 1999b, Essa et al. 2011, Murali et al. 2015). In vivo studies 
demonstrated that PEGylated and PVP-coated nanoparticles remained longer in the 
circulation due to their reduced attachment to vessel walls and cell surfaces (Peracchia et 
al. 1999a, Chilukuri et al. 2008, Fang et al. 2014). 
2.6. Detection of NPs in biological samples 
Observations on nanoparticle distribution in cells and whole organisms are indispensable 
to localize the sites of interaction with living structures. Combining visualization 
techniques with antibody-based labelling methods enables the identification of cells by 
molecular phenotype. This allows to interpret the presence of NPs within the biological 
context. 
Various imaging techniques can be used for localizing inorganic, metal or organic 
nanoparticles, yet all techniques have limitations, which often make NP-detection in the 
living body laborious. Here I introduce the advantages and disadvantages of the two most 
widely applied detection technique used to visualize inorganic nanoparticles. Several 
methods try to overcome the limitations of these techniques and meet the specific 
requirements of the detection of various types of NPs. 
2.6.1. Electron microscopy 
Transmission and scanning electron microscopy (TEM, SEM) can provide a very high 
spatial resolution (down to 0.1 nm) and magnification (Krijnse Locker and Schmid 2013, 
Begemann and Galic 2016). It gives detailed information on subcellular structures and 
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shows the precise localization of NPs. However, the sample preparation for electron 
microscopy is more time taking compared to other microscopic methods and is prone to 
artifacts. Artifacts may be caused by chemical fixation, dehydration and staining with 
lead citrate or uranyl acetate (Shah et al. 2015, Chen et al. 2016); this renders image 
interpretation challenging. Analysis of NP distribution and tissue effects with electron 
microscopy requires a deep understanding of normal and diseased cellular ultrastructure. 
Additionally, a certain electron density of NPs is required for a contrasted image, hence 
electron microscopy is more often used for the visualization of electron-dense inorganic 
and metal NPs.  
The time intensive sample preparation, the small analyzed volume and the limited 
analytical throughput of the method does not suggest to use electron microscopy as a 
high-throughput imaging technique for detecting NPs in tissues. 
2.6.2. Fluorescent light microscopy 
Fluorescent microscopy allows for a sensitive, efficient, and time- and cost-effective 
evaluation of large amounts of samples (Kobayashi et al. 2010). The capabilities of the 
technique largely satisfy demands by researchers and regulatory authorities. However, 
the resolution in optical microscopy is limited due to diffraction; the wavelength of light 
determines the maximum resolution of a microscope. The nanoparticle’s size (typically 
being between 1 and 100 nm) is below the diffraction limit of ~ 250 nm, thus, only NP 
that cluster or form aggregates can be visualized directly. 
NPs must be able to emit fluorescent light upon excitation to be detectable by fluorescent 
microscopy. Any surface labeling of NP, however, may possess the risk of changing their 
physicochemical characteristics and their bioreactivity. In contrast, NPs which 
encapsulate the fluorescent dye in their core structure and have an unlabeled shell leave 
the overall properties of NPs unchanged. 
Despite its favorable properties, the core-shell structure limits the amount of dye per 
particle, lowering brightness. Moreover, the detection is further hindered by the high 
autofluorescence intensity of biological samples (Figure 6), resulting in a limited 
visualization of NPs due to the low signal-to-noise ratio. 
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Figure 6: Extinction coefficient value of water, oxy- and deoxy-hemoglobin 
(Kobayashi et al. 2010) 
Naturally occurring endogenous fluorophores (mostly hemoglobin and related molecules) 
can be excited in the same wavelength range as fluorescently labelled NPs, leading to 
high autofluorescence in biological samples. 
Spectral imiging fluorescence microscopy provides a solution to overcome the limitations 
caused by low NP fluorescence intensity masked by high tissue autofluorescence. The 
technique combines conventional laser scanning confocal microscopy with a spectral 
detector (Figure 7). The basis of the image acquisition is that the emitted light of the 
sample is detected separately at consecutive wavelengths throughout a defined spectrum 
range, resulting a confocal image with spectral information about each pixel (Figure 8). 
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Figure 7: Spectral detector for spectral image acquisition  
The emitted light of the samlpe is separated into different wavelengths by a diffreaction 
grating and detected by a 32 channel multi-anode photomultiplier to accuire spectral 
images. With the different resolution of the diffraction grating, one can choose between 
greater spectral resolution (2.5nm, 6nm, 10nm) or wider detected spectrum range (∑range 
= 80nm, 192nm, 320nm). (DEES: Diffraction Efficiency Enhancement System, 
www.microscopyu.com) 
 
Figure 8: Confocal images with embedded spectral information 
A spectral image consists of fluorescence intensity images on 32 different wavelengths 
detected by the spectral detector. Emission spectral profile (spectrum) of evry pixel of the 
image can be drawn from the combined fluorescence intensity information. 
The emission spectrum of a label dye in NPs differs unequivocally from the emission 
spectra of autofluorescent signals, helping the identification of NPs. Additionally the 
technique enables the use of multiple fluorescent labels, that cannot be distinguished by 
conventional fluorescence microscopy due to overlapping emission spectra (Dickinson et 
al. 2001).  
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3. OBJECTIVES 
In the work, which provided the basis of the dissertation I investigated the 
physicochemical characteristics, and the interactions of fluorescent nanoparticles with 
biological material, including cellular uptake in vitro and tissue distribution in vivo. My 
interest was focused on the altered biological behavior of silica and polystyrene 
nanoparticles with equal size but coated with distinct functional groups; ranging from 
strong negative surface charges (PS-COOH, SiO2, SiO2-SH) to positive (SiO2-NH2) or 
passivated surfaces (PS-PEG, SiO2-PVP). Experimental work aimed to answer the 
following questions: 
 Are polystyrene- (PS-COOH, PS-PEG) and silica nanoparticles (SiO2, SiO2-NH2, 
SiO2-SH and SiO2-PVP) good models for investigating the effects of surface 
characteristics? 
 How does the chemical surface composition affect the behavior of NPs in 
inorganic or organic solutions? 
 Which cell types can interact with and internalize the distinct types of 
nanoparticles in serum-free in vitro conditions? 
 How do polystyrene nanoparticles with different surface functionalization 
penetrate into and clear from different organs and tissues? Special attention was 
paid to barrier functions of the blood brain barrier and the placenta, and to the 
accumulation and storage of nanoparticles in various organs. 
 Can the detection efficiency of fluorescent nanoparticles be improved? Does the 
adaptation of spectral imaging fluorescence microscopy provide a reliable 
imaging approach to distinguish particle-fluorescence from tissue 
autofluorescence? 
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4. METHODS 
4.1. Nanoparticles used in experiments 
4.1.1. Polystyrene nanoparticles 
Carboxylated or PEGylated (MwPEG = 300 g/mol) nanoparticles with nominal size of 
50-70 nm made from “Yellow” or “Nile-Red” fluorochrome-labelled polystyrene were 
obtained from Spherotech Inc. (Lake Forest, IL, USA). Concentration of the stock 
suspensions was 10 mg/ml, fluorescence spectrum was provided by the manufacturer 
(Figure 9). 
FITC-labelled 50-70 nm nanoparticles were purchased from Kisker Biotechnology Gmbh 
(Steinfurt, Germany), with or without 600 Da or 2 kDa PEG chains on the NP surfaces. 
 
Figure 9: Fluorescence spectra of PS-NP 
Fluorescence spectra of “Yellow” and “Nile-Red” PS-NP provided by the manufacturer, 
together with the spectra of other commercially available fluorescent nanoparticles 
(Spherotech). 
4.1.2. Silica nanoparticles 
Fluorescent silica nanoparticles with a core-shell structure were synthesized, 
functionalized and characterized by Emilia Izak-Nau at Bayer Technology Services, 
GmBH, Germany (results summarized in (Izak-Nau et al. 2013a)). 50 nm SiO2 
nanoparticles encapsulating fluorescein-isothiocyanate (FITC, ≥90%, Fluka, Seelze, 
Germany) were synthesized with modified Stöber method (Stöber et al. 1968). The 
surface of NPs was either coated with polyvinylpyrrolidone (PVP K-15, Sigma-Aldrich, 
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Germany) or modified to generate amino and mercapto surface groups by addition of 3-
aminopropyltriethoxysilane (APTES, 98 %, Alfa Aesar) and 3-
mercaptopropyltrimethoxysilane (MPTMS, Sigma-Aldrich) organosilanes, respectively. 
4.2. Physicochemical characterization of polystyrene nanoparticles 
4.2.1. Dynamic light scattering (DLS) measurements 
Size of nanoparticles was measured by dynamic light scattering with a ZetasizerNano 
ZS90 (Horiba Instruments Inc., Irvine, CA). Measurement was carried out at 25°C. Light 
beam was produced by using a 633 nm He-Ne laser, which was scattered by the 
nanoparticles in the measuring chamber. 
Time dependent increase in particle diameter (indicator of nanoparticle aggregation) was 
monitored in inorganic or biological environments, including solutions used during 
particle handling and solutions that mimic the characteristics of body fluids. Carboxylated 
and PEGylated polystyrene nanoparticles (1 mg/ml in distilled water) were diluted 1:10 
with PBS (pH 7.4), DMEM cell culture medium (Sigma-Aldrich, St. Louis, MO, USA) 
or DMEM supplemented with 10% fetal bovine serum (Invitrogen/Gibco, Carlsbad, CA, 
USA). After 0, 4, 24 or 96-hour incubation at 37°C, particle preparations were further 
diluted in 1:10 with distilled water and the hydrodynamic diameter of particles was 
measured by DLS. 
Three samples were assayed in each condition (Nx = 3) and each assay was repeated 3 
times (Σnx = 9). When initial size distribution of PS-COOH and PS-PEG particles was 
measured in distilled water, Kolmogorov-Smirnov normality test showed Gaussian 
distribution of experimental data (ΣnCOOH = 9, ΣnPEG = 9). To compare the size 
distribution of PEGylated and COOH-nanoparticles unpaired t-test was used on the 
averaged data of repeated measurements (NCOOH = 3, NPEG = 3) defined by mean, SD and 
the number of repeated measurements (n = 3). 
4.2.2. Transmission electron microscopy measurements 
Size and shape of nanoparticles were confirmed by transmission electron microscopy 
(TEM, JEOL JEM 1010, JEOL Ltd., Tokyo, Japan). For TEM analysis, 3 µl aliquots of 
0.01 mg/ml nanoparticle suspensions in distilled water were transferred to and dried on 
200 mesh copper grids with carbon film. Microscope was operated at 80 keV accelerating 
voltage. Images were taken from representative fields of views. 
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4.2.3. Zeta-potential measurements 
Zeta-potential of nanoparticles was measured by ZetasizerNano ZS90 (Horiba 
Instruments Inc.). The technique is based on the measurement of the migration rate of 
dispersed particles in an electric field, providing the electrophoretic mobility of NPs as a 
result. The zeta-potential is calculated from the electrophoretic mobility by the software 
using the Henry equitation. Measurements were carried out in distilled water on 3 
parallels of 0.01 mg/ml nanoparticle suspensions (NCOOH = 3; NPEG = 3) at 25°C with a 
folded capillary cell (DTS1070, Malvern Instruments, Worcestershire, United Kingdom). 
The measurements were repeated 3 times. Kolmogorov-Smirnov normality test showed 
Gaussian distribution of experimental data (ΣnCOOH = 9, ΣnPEG = 9). To compare the zeta-
potential of PEGylated and COOH-NPs unpaired t-test was used on the averaged data of 
repeated measurements (NCOOH = 3, NPEG = 3) defined by mean, SD and number of 
repeated measurements (n = 3). 
4.2.4. Assays on protein adsorption 
Proteins adsorbed by particles in 10% fetal bovine serum containing minimum essential 
medium (FBS-MEM; Sigma-Aldrich, St. Louis, MO, USA) were analyzed by SDS-
PAGE (Sodium dodecyl sulfate polyacrylamide gel electrophoresis). After 1 hour or 24-
hour incubation in 10% FBS-MEM nanoparticles were sedimented by centrifugation 
(45min at 20000 x g) and were washed with PBS to remove non-bound proteins. Washed 
NPs were resuspended in Laemmli buffer containing 1% (w/v) sodium dodecyl sulfate, 
and loaded onto 10% polyacrylamide gel. Gel electrophoresis was performed at 130 V 
for about 60 min. The gels were stained with silver staining 33 kit (Cosmobio Ltd., Tokyo, 
Japan), according to the manufacturer’s instructions. 
4.3. Cell cultures 
4.3.1. Primary astroglial and neuronal cultures 
Cell suspensions of primary brain cell cultures (Madarasz et al. 1984) were prepared by 
mechanical dissociation of embryonic (E14-19) mouse forebrains, or by combined 
enzymatic dissociation (Neural Tissue Dissociation Kit, Miltenyi Biotec) of early 
postnatal (P0-P3) mouse forebrains (Környei et al. 2000). Single cell suspension was 
obtained by filtering the dissociated suspension through a nylon mesh with pore diameter 
of 40 m. Cells were seeded onto cell culture plates containing poly-L-lysine (PLL, 
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Sigma-Aldrich) coated cover slips, in 4*105 cells/cm2 density. Primary cell cultures were 
maintained in 10% heat-inactivated FCS containing MEM, supplemented with 4mM 
glutamine, 2.5 µg/ml Amphotericin-B (Fungizone, Sigma) and 40 µg/ml gentamycin 
(Sanofi-Aventis/Chinoin) and kept in 5% CO2 containing humidified air atmosphere, at 
37°C. Medium was changed two times a week. 
Astroglia-enriched cultures were prepared by changing the 10% serum containing 
medium on primary cultures every second day for two weeks. 
Neuron-enriched cultures were prepared by treating primary cultures with the anti-mitotic 
10 M CAR (cytozin-arabino-furanozid, 10 M), for 24hs, on the 4th-5th days after 
planting. Afterwards cultures were maintained in 10% horse serum (Bioser) containing 
MEM. 
4.3.2. Primary microglial cultures 
Microglial cultures were prepared according to (Saura et al. 2003) from newborn mice. 
GFP-labelled microglia cells were isolated form mice expressing a green fluorescent 
protein under the control of CX3CR1 gene promoter (Jung et al. 2000). 
First, mixed glial cultures were prepared from the forebrains of newborn (1–2 days old) 
mouse pups. The meninges were carefully removed and the brain tissue was incubated 
with 0.05% (w/v) trypsin solution supplemented with 1 mM EDTA. After 5 to 10 min 
incubation, the tissue was mechanically dissociated. Suspensions of single cells were 
seeded in 1:1 mixture of DMEM-F12 with 10% FCS and cultured at 37°C in 5% CO2 
containing humidified air atmosphere. Medium was replaced every 3–4 days. 
After 10–12 days’ cultivation, the confluent mixed glial cultures were trypsinized with 
0.05% (w/v) trypsin in the presence of 0.2 mM EDTA and 0.5 mM Ca2+. After detachment 
of astrocytes, the firmly attached microglial cells were further propagated in 1:1 mixture 
of DMEM-F12 supplemented with 10% FCS. 
4.3.3. BV2 microglial cells 
BV2 is a microglial cell line isolated from C57Bl mouse generated by infecting primary 
microglial cell cultures with a v-raf/v-myc oncogene carrying retrovirus (Blasi et al. 
1990). BV2 cells retain most of the morphological, phenotypical and functional properties 
described for freshly isolated microglial cells. Namely BV2 cells are positive for MAC1 
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and MAC2 antigens, and negative for GFAP, MAC3 and galactocerebroside antigens 
(Blasi et al. 1990). 
4.3.4. NE-4C stem cells 
NE-4C neuroectodermal stem cells (Schlett and Madarász 1997) were cloned from 
primary brain cell cultures prepared from the fore- and midbrain vesicles of 9-day-old 
transgenic mouse embryos lacking functional p53 tumor suppressor protein. NE-4C can 
be differentiated into neurons and astrocytes by retinoic acid induction. The retinoic acid 
induced neural differentiation of NE-4C cells is a highly reproducible process, where the 
differentiation steps follow each other in a strict order (Schlett et al. 1997, Varga et al. 
2008, Hádinger et al. 2009, Madarász 2013) (Figure 10). 
 
Figure 10: The schematic representation of retinoic acid induced neural 
differentiation of NE-4C cells 
Neural differentiation is induced by a short RA-treatment, which at first initiates the 
aggregation of cells, and primes the differentiation process. Later, the differentiation 
proceeds in both serum-containing and serum-free culture conditions. Neuron specific 
markers are expressed from the 6-7th day after RA-treatment, glia genesis starts at 7-10 
days after RA-priming. (Madarász 2013) 
NE-4C neuroectodermal stem cells were maintained in poly-L-lysine (Sigma-Aldrich) 
coated culture dishes, in minimum essential medium (MEM; Sigma-Aldrich, Hungary) 
supplemented with 4 mM glutamine and 5% FCS (FCS; Sigma-Aldrich). Culture dishes 
were kept in 5% CO2 containing humidified air atmosphere, at 37°C. 
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To induce differentiation 10-6 M all-trans retinoic acid (RA; Sigma-Aldrich, Hungary) 
was added to confluent cultures of NE-4C cells for 48 hours. After 48-hour treatment with 
RA, the culture medium was changed to serum-free medium (1:1 mixture of MEM-F12 
supplemented with 1 % ITS (Sigma-Aldrich)), and fresh media was given every second 
day during differentiation. 
For mature neurons, identified by βIII-tubulin positivity, cultures on the 7th to 9th days of 
induction were used. GFAP positive astroglia cells appear in the second week of 
induction, 5-7 days after the appearance of neuron-like cells. 
4.3.5. Radial glia 
Cultures of adult radial glia-like cells (Markó et al. 2011) were established from 
hippocampi and subventricular zones of 21 day-old CD1 mice by enzymatic dissociation 
using the Neural Tissue Dissociation Kit (Miltenyi Biotec) according to the 
manufacturer’s instructions. Dissociated cells were plated onto cell culture plates coated 
with AK-cyclo[RGDfC] (Markó 2008) and maintained in 1:1 mixture of MEM-F12 
supplemented with 1% B27 supplement (Gibco) and 20 ng/ml EGF (Peprotech). The 
medium was changed every second day after rapid rinsing with PBS in order to wash off 
weakly adhering cells. After 3-4 passages, cultures the cultures contained virtually 
homogeneous populations of radial glia-like cells, which can proliferate continuously and 
display radial glia-specific markers (including nestin, RC2 immunoreactivity and Pax6, 
Sox2, Blbp, Glast gene expression). 
Under appropriate inducing conditions, radial glia cells can differentiate into neurons, 
astrocytes or oligodendrocytes depending on the culture conditions (Markó et al. 2011). 
4.4. In vitro uptake of nanoparticles 
For cellular uptake studies cell cultures were grow on poly-L-lysine coated glass 
coverslips in 24 well plates. The cells were incubated with nanoparticle suspension 
dispersed in 1:1 mixture of MEM:F12 supplemented with 1 % ITS (MEM-F12-ITS) or 
with 1% B27 (MEM-F12-B27) for 30min to 1 h at 4 °C or 37 °C in air with 5% CO2. 
Summary of treatment conditions are shown in Table 1. Control cultures were incubated 
under the same conditions, but without the addition of nanoparticles.  
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Table 1: Nanoparticle concentrations used in uptake experiments 
Nanoparticle Concentration Volume Solution 
SiO2 5 x 10
11 NPs/ml 500 µl MEM-F12-ITS 
SiO2-NH2 5 x 10
11 NPs/ml 500 µl MEM-F12-ITS 
SiO2-SH 5 x 10
11 NPs/ml 500 µl MEM-F12-ITS 
SiO2-PVP 5 x 10
11 NPs/ml 500 µl MEM-F12-ITS 
PS-COOH 
3.5 x 1010 NPs/ml to 
2 x 1011 NPs/ml 
500 µl 
MEM-F12-ITS or 
MEM-F12-B27 
PS-PEG 
3.5 x 1010 NPs/ml to 
2 x 1011 NPs/ml 
500 µl 
MEM-F12-ITS or 
MEM-F12-B27 
After incubation, the samples were washed three times with phosphate buffered saline 
(PBS, pH 7.4) to remove free-floating NPs and fixed for 20 min with paraformaldehyde 
(PFA, 4% w/v) at room temperature. 
4.5. In vivo distribution of polystyrene nanoparticles 
Animal experiments were conducted with the approval of the Animal Care Committee of 
the Institute of Experimental Medicine of Hungarian Academy of Sciences and according 
to the official license (No.: 22.1/353/3/2011) issued by National Food Chain Safety Office 
(www.NEBIH.gov.hu), Hungary.  
Male mice (aged 25-30 days) and pregnant female mice on the 10th to 15th post 
conception days were anesthetized with a mixture of ketamine (CP-Pharma mbH, 
Burgdorf, Germany) and xylazine (CEVA-PHYLAXIA, Budapest, Hungary), 100 µg/g 
and 10 µg/g bodyweight, respectively. Stock suspensions (10 mg/ml) of polystyrene 
nanoparticles were diluted 1:30 in PBS and dispersed by sonication. Under proper 
anesthesia, 7 µl/g bodyweight aliquots of carboxylated or PEGylated nanoparticle 
suspensions were introduced into the tail vein. Animals were sacrificed by overdose of 
anesthetics after a 5-minute or 4-day exposure to the single-injection loading. Various 
organs including brain, liver, kidney, spleen as well as placenta and embryos were 
removed and fixed with paraformaldehyde (8 w/v% in PBS) for 24 hours at 4ºC. Organs 
and embryos were collected from animals not exposed to nanoparticles, as controls. 
4.6. Microscopic evaluation 
Cellular uptake of nanoparticles by cultured cells and in vivo penetration into various 
tissues were examined using Zeiss Axiovert 200M microscope (Carl Zeiss Microimaging, 
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Jena, Germany) and Nikon A1R Confocal Laser Microscope System (Nikon, Shinjuku, 
Tokyo, Japan) equipped with a spectral detector unit for fluorescence spectrum analysis. 
For microscopic evaluation, 30 or 60 µm thick vibratome sections (VT1000S, Leica, 
Wetzlar, Germany) were made from fixed organs. 
4.6.1. Immunohistochemical procedures 
For visualization of intracellular antigen epitopes, fixed cells or tissue sections were 
permeabilized with Triton X-100 (10 min, 0.1% v/v in PBS) and non-specific antibody 
binding was blocked by incubating the sections in PBS containing 10 % FBS for 2 hours. 
Primary antibodies were diluted in 1 to 1000 with PBS-FBS, and the preparations were 
incubated at 4ºC, overnight. After incubation, the cells/sections were washed three times 
(15 min each) with PBS and incubated with alexa-594 conjugated secondary antibodies 
for 1 h. Cell cultures were occasionally stained with CellMask (Molecular Probes, 
Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions, to visualize 
cell membranes. Detailed information on primary and secondary antibodies are shown in 
Table 2. 
Preparations were mounted with mowiol (Sigma-Aldrich, Budapest, Hungary) containing 
10 μg/ml bisbenzimide (Sigma-Aldrich) for nuclear staining. 
Table 2: Antibodies used during immunocytochemical stainings 
Primary antibodies Dilution Provider 
anti-Iba-1 (polyclonal goat) 1:1000 Abcam; Cambridge, UK 
anti-claudin V (polyclonal rabbit) 1:1000 Abcam; Cambridge, UK 
anti-GFAP (monoclonal mouse) 1:1000 Sigma-Aldrich, Budapest, Hungary 
anti-β-III tubulin (monoclonal mouse) 1:1000 Sigma-Aldrich, Budapest, Hungary 
Secondary antibodies   
anti-goat alexa-594 conjugated AB 1:1000 Molecular Probes, Carlsbad, USA 
anti-rabbit alexa-594 conjugated AB 1:1000 Molecular Probes, Carlsbad, USA 
anti-mouse alexa-594 conjugated AB 1:1000 Csertex Kft., Budapest, Hungary 
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4.6.2. Detection of particles by spectral imaging fluorescence microscopy 
For enhanced detection of nanoparticles and identification of NP-derived fluorescence 
spectral imaging fluorescence microscopy was adapted. Fixed cells or tissue sections 
were examined using Nikon A1R Confocal Laser Microscope System (Nikon, Shinjuku, 
Tokyo, Japan) equipped with a spectral detector unit for spectral acquisition. 
For spectral evaluation 457 nm argon ion laser was used as excitation source for “Yellow” 
PS-NP treated samples and the corresponding controls. The emitted light was detected by 
the spectral detector unit from 468 nm to 548 nm, with a spectral resolution of 2.5 nm. In 
order to record continuous spectrum, a 20/80 beam splitter (BS20/80) with continuous 
transmission was used instead of a paired dichronic mirror arrangement. 
For the detection of other fluorophore labelled particles microscopic arrangement was 
similar, only the excitation and detection wavelengths were changed (Table 3). 
Table 3: Excitation wavelengths and detection ranges for nanoparticles core-
labelled with different fluorochromes 
Fluorophore 
Excitation 
wavelength 
Detection range 
Spectral 
resolution 
SR (emitted 
light intensity 
ratio 
"Yellow" 457 nm 468-548 nm 2.5 nm 483/528 nm 
"Nile Red" 514 nm 535-727 nm 6 nm 560/670 nm 
FITC 488 nm 490-570 nm 2.5 nm 515/550 nm 
Post hoc fluorescence spectrum analysis was carried out on selected spectral images. To 
establish positive and negative controls for the analysis, fluorescence spectra of NPs were 
determined in dry and in buffer-dispersed particle preparations, as well as in contact with 
fixed tissue sections made from control animals. The spectra emitted by the particles in 
contact with the corresponding tissue section from control animals were used as positive 
controls. For negative control, the intrinsic autofluorescence spectra of corresponding 
sections of control organs were used. 
Regions of interest (ROIs) were delineated and analyzed in corresponding sections of 
nanoparticle-treated and non-treated organs. The photocurrent intensities detected at 
different wavelengths (emission spectra) in the sections of NP-treated animals were 
plotted against the tissue autofluorescence spectra (negative control) and the spectra of 
nanoparticles seeded on control-tissue (positive control). 
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To quantitatively classify NP-containing ROIs a spectral ratio (SR) was calculated from 
the fluorescence intensities at reference wavelengths corresponding to the intensity 
maximums of NP-fluorescence and tissue autofluorescence (Table 3). For samples 
containing “Yellow” labelled polystyrene NPs the SR was calculated by dividing the 
relative fluorescence intensities at 483nm and 528nm reference wavelengths. ROIs were 
considered as NP-containing if the spectral ratio was above 1 (SR > 1).  
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5. RESULTS 
5.1. Physicochemical characterization of nanoparticles 
To compare the physicochemical characteristics of the differentially functionalized 
nanoparticles and to understand the differences in their interactions with the living 
material, thorough characterization of NPs was crucial. The physical and chemical 
parameters of particles were determined including hydrodynamic and dry size, 
aggregation properties, and protein adsorption. The changes of these parameters were 
monitored in distinct inorganic or biological environments, including solutions used 
during particle handling and solutions that mimic the characteristics of body fluids. 
5.1.1. Polystyrene nanoparticles 
Polystyrene nanoparticles with carboxylated or PEGylated surfaces were used in the 
studies. The properties of these particles were analyzed in details and compared to each 
other. 
Dynamic light scattering measurements revealed that the diameter of the two NPs did not 
differ significantly (Figure 11 A and B; 70.81 ± 21.09 nm and 68.69 ± 18.68 nm for PS-
COOH and PS-PEG, respectively). The data showed that particles did not aggregate in 
distilled water. Transmission electron microscopic images showed slight agglomeration 
of dried particles and confirmed spherical shape of NPs (Figure 11 A and B inserts).  
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Figure 11: Size distribution of PS-NP 
Intensity weighted size distribution of carboxylated (A; NCOOH = 3) and PEGylated (B; 
NPEG = 3) polystyrene nanoparticles measured by dynamic light scattering in distilled 
water. Three repeated measurements were carried out on each sample. Average size of 
the NPs is marked with red. DLS measurements showed no significant difference between 
PS-COOH and PS-PEG NPs (unpaired t-test was carried out on the averaged data of 
repeated measurements (N = 3, Σnx = 9) defined by mean, SD and number of repeated 
measurements (n = 3), p = 0.3622) Representative transmission electron microscopic 
images of particles dried on copper grids are shown in the top right panels of each DLS 
plot. Scale bars represent 400 nm. 
The zeta potential of particles measured in distilled water showed significant (p ˂ 0.0001; 
unpaired t-test) differences between the two NPs: −42.1 ± 0.9 mV for PS-COOH and 
−28.5 ± 1.8 mV for PS-PEG particles. 
Based on the hydrodynamic particle size distributions, neither of the NPs did aggregate 
in distilled water or in PBS during a 96-hour assay period (Figure 12), indicating that the 
ionic strength of organic material-free physiological saline did not induce aggregation of 
PS-COOH and PS-PEG nanoparticles. 
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Figure 12: Aggregation properties of PS-NP in inorganic solutions 
Particles were incubated in distilled water or PBS for 96 hours, while size distribution 
was monitored via DLS at certain time points. Data are presented as mean ± standard 
deviation (N = 3 in each group; three repeated measurements were carried out on the 
samples). 
In contrast to inorganic solutions, a time-dependent, heavy aggregation of both NPs was 
found in serum-free DMEM (Table 4 and Figure 13). DMEM has an ionic strength similar 
to PBS, but contains various organic compounds including glucose, amino acids, vitamins 
and non-peptide hormones. In DMEM, a moderate increase in the hydrodynamic size was 
already observed after 4-hour incubation, and was found to be robustly elevated after 96 
hours. The kinetics of particle enlargement was consistent with an immediate deposition 
of material on particle surfaces and a large-scale aggregation thereafter. The data showed 
that PEG-coating reduced the aggregation in long-term incubation (Figure 13). 
Table 4: Size distribution of PS-NP in DMEM 
Data are presented as mean ± standard deviation (NCOOH = 3, NPEG = 3). 
  
Size (nm) 
5 min 4h 24h 96h 
PS-COOH 66.40 ± 0.82 116.90 ± 2.10 178.47 ± 17.39 851.77 ± 34.27 
PS-PEG 68.55 ± 0.45 115.93 ± 0,60 182.07 ± 30.53 559.67 ± 141.11 
The incubation of nanoparticles with 10% fetal bovine serum containing DMEM evoked 
an immediate size increase, but prevented the large-scale aggregation of nanoparticles 
thereafter (Figure 13). The observation indicated that serum components were 
immediately adsorbed by particle surfaces, but instead of cross-linking particles, the 
protein corona could stabilize the suspension of dispersed particles. 
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Figure 13: Aggregation properties of PS-NP in organic solutions 
Particles were incubated in DMEM or DMEM supplemented with 10% FBS for 96 hours, 
while size distribution was monitored via DLS. Data are presented as mean ± standard 
deviation (N = 3 in each group; three repeated measurements were carried out on the 
samples). 
Electrophoresis data further verified the rapid adsorption of proteins to both PS-COOH 
and PS-PEG nanoparticles (Figure 14A). PEG-coated nanoparticles exhibited reduced 
protein adsorption, which was evident after 24 hours incubation (Figure 14B) suggesting 
that PEGylation makes nanoparticles less prone to interactions with the environment. 
 
Figure 14: Adsorption of serum proteins to polystyrene nanoparticles 
PS-COOH and PS-PEG particles were incubated for 1h or 24h in 10% FBS containing 
MEM and analyzed by SDS-PAGE. 
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5.1.2. Silica nanoparticles 
50 nm spherical silica nanoparticles with a core-shell structure contained FITC 
encapsulated in the core. Surface of nanoparticles was coated either with PVP (SiO2-
PVP), modified with amino (SiO2-NH2) or mercapto (SiO2-SH) functional groups, or left 
unmodified (SiO2-NP), generating four different types of SiO2-NPs, namely: SiO2-NP, 
SiO2-PVP, SiO2-NH2, SiO2-SH. 
Synthesis,  characterization and protein adsorption measurements of silica NPs was 
conducted by Emilia Izak-Nau and summarized in two publications (Izak-Nau et al. 
2013a, 2013b). Here I present only briefly the basic properties of silica nanoparticles that 
are necessary to understand and interpret in vitro uptake results and to show the 
importance of the chemical surface composition in nano-bio interactions. 
TEM and DLS measurements confirmed the size, spherical shape and monodispersity of 
the pristine silica particles (Figure 15) and the surface functionalized particles as well 
(Figure 16). 
 
Figure 15: Silica nanoparticles are spherical and monodisperse 
TEM (A) and DLS (B) measurements show spherical shape and monodispersity of 
pristine SiO2-NPs. Size measured by DLS was 52.5 ± 2.6nm (Izak-Nau et al. 2013a). 
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Figure 16: Size and shape of surface functionalized SiO2-NPs 
TEM (A, C, E) and DLS (B, D, F) analyses of SiO2-NPs functionalized with amino groups 
(SiO2-NH2) (A, B), with mercapto groups (SiO2-SH) (C, D) or with polyvinylpyrrolidone 
(SiO2-PVP) (E, F) shows stability of NPs after functionalization (Izak-Nau et al. 2013a). 
Size measured by DLS: 56.0 ± 4.6 nm for SiO2-NH2, 49.9 ± 2.2 nm for SiO2-SH and 59.5 
± 2.3 nm for SiO2-PVP. 
The zeta potential of particles measured by DLS was -41.71 ± 0.82 mV for SiO2-NPs, 
+42.24 ± 1.49 for SiO2-NH2, -47.73 ± 0.91 mV for SiO2-SH and -40.87 ± 1.31 mV for 
SiO2-PVP (Izak-Nau et al. 2013a). 
Aggregation properties and protein adsorption of silica nanoparticles was investigated 
with DLS and SDS-PAGE after incubation with fetal calf serum. All particles, with the 
exception of the PVP-coated particles, showed aggregation in cell culture media (Table 
5). Additionally, PVP-coating markedly reduced the adsorption of serum proteins to the 
surface of silica NPs (Figure 17). 
Table 5: Size distribution of silica NP in cell culture media analyzed by DLS 
  Size (nm) 
  SiO2 SiO2-NH2 SiO2-SH SiO2-PVP 
MEM 
1626 ± 260 1892 ± 423 1844 ± 818 67 ± 4 
(48h; RT; 1x1014 NPs/ml) 
MEM-sonication 10 min 
785 ± 156 873 ± 199 932 ± 176 65 ± 3 
(48h; RT; 1x1014 NPs/ml) 
MEM-F12-ITS 
1119 ± 62 976 ± 163 1247 ± 137 68 ± 6 
(1h; 37°C; 5x1011 NPs/ml) 
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Figure 17: Adsorption of serum proteins on silica NP 
SDS-PAGE analysis of silica nanoparticles after 1-hour incubation in 10% FCS 
containing PBS. M: molecular weight marker (Izak-Nau et al. 2013a). 
Physicochemical characterization revealed that both polystyrene and silica nanoparticles 
gave stable, monodisperse suspensions in storage conditions. Surface functionalization 
resulted in different surface charges, but did not affect the dispersion stability in inorganic 
solutions. In contrast, particles were prone to aggregation in organic solutions, a 
phenomenon, which was reduced by PEGylation or PVP-coating. 
5.2. In vitro cellular uptake of nanoparticles 
5.2.1. Interaction of PS-NPs with neural stem- and tissue-type cells 
To obtain information on the differential uptake of polystyrene nanoparticles primary 
cultures, containing mixed neural and glial cell populations were exposed to carboxylated 
and PEGylated particles. 
In general, incubation with 3.5 x 1010 NPs/ml to 2 x 1011 NPs/ml polystyrene 
nanoparticles (diameter: 50-90nm) in serum free conditions did not result in obvious 
structural damage to cells after 1-hour incubation. In serum free media PS-COOH formed 
light microscopically detectable agglomerates. Within a 1 h exposure time, the 
agglomerates settled on cell surfaces and on the glass coverslip, and remained visible after 
multiple washing. PEGylated NPs, on the other hand, could wash off and were hardly 
visible outside of the cells. 
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When primary brain cell cultures containing neurons, astrocytes and microglia cells were 
exposed to PS-COOH nanoparticles, cells with microglial morphology accumulated a 
remarkable amount of NPs. GFAP positive astrocytes and neurons, identified by βIII-
tubulin positivity, were devoid of carboxylated particles (Figure 18). 
 
Figure 18: GFAP and βIII-tubulin negative cells with microglial morphology take 
up PS-COOH in primary forebrain cultures 
Primary mouse forebrain cultures, prepared from E17 embryos, were maintained for 14 
days in glial-enriched culture (A) or in neuron-enriched culture for 6 days (B), were 
exposed to “yellow” fluorophore labelled PS-COOH nanoparticles (green) in serum free 
conditions for 1 h. Astrocytes were identified by GFAP staining (A, red) or neurons were 
visualized by βIII-tubulin immunostaining (B, red) and cell nuclei by bisbenzimide 
nuclear staining (blue on A). (Murali et al. 2015) 
To investigate whether the accumulated particles were internalized through active cellular 
processes, uptake experiments were run at +4°C and 37°C on primary cultures. In cell 
cultures incubated at +4°C, cells “labelled” by particles displayed markedly different 
morphology compared to 37°C-incubated ones (Figure 19). 
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Figure 19: Uptake of PS-COOH is activity dependent 
Mixed glial culture (from E18 mouse forebrain, 21 days after planting) was exposed to 
3.5 x 1010 NPs/ml carboxylated polystyrene NP at 37°C (A) or +4°C (B). Cells with 
microglial morphology (small rounded cells in A) no longer took up particles when 
incubated at 4°C. Green: PS-COOH; yellow: GFAP, blue: nuclear staining. 
Additionally, confocal microscopic z-stack analysis showed that at low temperatures NPs 
did not accumulate inside the cells, but were only attached to cell surfaces (Figure 20). 
 
Figure 20: Nanoparticles do not accumulate inside the cells at low temperatures 
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Primary brain culture exposed to PS-NP from E15 mouse 21 days after isolation. Z-stack 
images show cellular uptake at 37°C (A), but only surface attachment at 4°C (B). Cell 
membranes were visualized with CellMask lipid staining (red). Particle fluorescence 
(green), nuclear staining (blue). (Experiments carried out with Kornél Demeter)  
The uptake of polystyrene particles by microglia was further investigated in BV2 cells 
(Blasi et al. 1990) and in purified microglia cultures of GFP-labelled microglia cells 
expressing a green fluorescent protein under the control of fractalkine receptor 1 
(CX3CR1) gene promoter (Jung et al. 2000). In 30 min exposure experiments (at 37°C) 
BV2 microglia cells internalized significant amount of carboxylated polystyrene 
nanoparticles, but were only sporadically labelled by PEG-functionalized particles 
(Figure 21). 
 
Figure 21: BV2 cells after 30min exposure to PS-NP 
BV2 cells exposed to “nile-red”-labelled PS-COOH (A) or PS-PEG (B) nanoparticles 
(red) for 30 minutes in serum free conditions. Non-treated control culture (C). Cultures 
were stained with bisbenzimide nuclear staining (blue). 
Similarly to BV2 cells, CX3CR1 GFP-labelled microglia cells accumulated remarkable 
amount of carboxylated particles, while did not take up PEGylated nanoparticles (Figure 
22). Confocal microscopic video images during 1h exposures of GFP-labelled CX3CR1 
microglia cultures (green) to “nile-red” PS-COOH (red) nanoparticles 
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(https://www.dropbox.com/s/bo4h8ibokxkgua5/in_vitro_PSNP_uptake_by_microglia_1.avi?dl=0 and  
https://www.dropbox.com/s/1riwi4bqhd44a52/in_vitro_PSNP_uptake_by_microglia_2.avi?dl=0) 
showed that projections took up remarkably high amount of carboxylated particles during 
exposure, which were transferred towards the soma afterwards. 
 
Figure 22: Primary microglia cells take up carboxylated NPs 
GFP-labelled microglia cells expressing a green fluorescent protein under the control of 
CX3CR1 gene promoter were treated with “nile red”-labelled (red) PS-COOH (A, C) or 
PS-PEG (B, D) nanoparticles for 30min. Red: particle fluorescence, green: GFP, blue: 
bisbenzimide nuclear staining. Non-treated control culture is shown in E. 
Primary cultures, regardless of the majority of neural or glial populations, always contain 
a number of non-differentiated, progenitor type cells. We investigated the nanoparticle 
uptake of progenitor cells on NE-4C neuroectodermal stem cells (Schlett and Madarász 
1997) and purified of radial glia cells (Markó et al. 2011). Progenitor cells did not take 
up polystyrene NPs, when incubated with 3.5 x 1010 NPs/ml suspensions for 1 hour 
(Figure 23). 
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We could conclude, that microglia cells are the primary collectors of PS-COOH NPs in 
mixed neural cultures. The almost complete lack of particles inside the cells after particle-
loading at low temperature indicate that the uptake is an active, energy-dependent 
process. The uptake of PS-NPs was effectively inhibited by PEGylation of the particle 
surfaces. 
 
Figure 23: Progenitor cells do not take up polystyrene nanoparticles 
Cloned embryonic neuroectodermal NE-4C stem cells (A, B) and radial glia cells (C, D) 
after 30-minute exposure to polystyrene NP. Cultures were treated with 3.5 x 1010 NPs/ml 
PS-COOH (A, C) or PS-PEG (B, D) NPs. Particle fluorescence is shown in red; cell nuclei 
are marked with blue nuclear staining. Half of the image in A and B is showing merged 
phase contrast and blue-fluorescence image of the same field. 
5.2.2. Interaction of Si-NP with neural stem- and tissue-type cells 
Uptake of fluorescently labelled core/shell SiO2 NPs with 50nm size was investigated on 
various cell types. In general, incubation with silica nanoparticles in serum free conditions 
did not cause structural damage to the investigated cells. After 1-hour incubation with 
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500 µl of 5 x 1011 NPs/ml nanoparticles the morphology of cells was similar to control 
conditions. 
Plain SiO2-NPs and amino- or mercapto-modified silica nanoparticles (SiO2-NH2 and 
SiO2-SH) formed light microscopically detectable agglomerates. Within 1 h exposure, the 
agglomerates settled on both the cell surfaces and the glass substrate, and were not 
removed by multiple washing. In clear contrast, PVP-functionalized silica particles did 
not form agglomerates and/or were washed off from the surfaces. 
In mixed glial cultures, plain SiO2, SiO2-NH2 and SiO2-SH nanoparticles were seen in 
aggregates on the cell-free substrate, on astrocytes and more abundantly, in GFAP-
negative (supposedly microglia) cells (see white arrow in Figure 24A). PVP-
functionalized silica particles, on the other hand, were not taken up by glial cells and 
washed off from the substrate and cellular surfaces more easily compared to the other 
types of SiO2-NP (Figure 24). 
 
Figure 24: Cultures of mouse forebrain glial cells exposed to silica NPs 
Confocal images of forebrain glial cultures non treated (B) or treated with SiO2 (A) or 
SiO2-PVP NPs (C). After 1 h exposure, SiO2 NPs adsorb onto astrocyte surfaces and to 
the culture surface, while SiO2-PVP are easily washed out. Red: astrocytes stained for 
GFAP; blue: cell nuclei stained with bisbenzimide; green: fluorescent SiO2 NPs. 
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Tree-dimensional reconstruction of a GFAP positive astrocyte from serial confocal 
images confirmed that SiO2-NPs were deposited on the cell surface, but were not engulfed 
by the cell (Figure 25).   
 
Figure 25: Z-stack confocal image of SiO2-treated astrocyte  
GFAP positive astrocyte shows surface attachment of nanoparticles, indicating that SiO2 
NPs were not internalized by astrocytes. Yellow cross in the confocal image marks the 
pane of z-stack cross section for side views. Red: astrocytes stained for GFAP; blue: cell 
nuclei; green: fluorescent SiO2 NPs. 
Primary brain cultures enriched in neurons showed no neuronal uptake of any type of 
silica particles. After 1-hour exposure a few agglomerates were found on cellular 
surfaces. Confocal z-stack images confirmed the surface attachment and external 
localization of these agglomerates (Figure 26). 
 
Figure 26: Cultured embryonic mouse forebrain neurons exposed to silica NPs 
Confocal images of primary cultures enriched in neurons non-treated (A) or treated with 
pristine SiO2 (B) or SiO2-PVP nanoparticles (C). After 1 h exposure, neurons did not 
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internalize any of the nanoparticles. Red: neurons stained for βIII-tubulin; blue: cell 
nuclei stained with bisbenzimide; green: fluorescent NPs. 
Plain SiO2 nanoparticles, SiO2-NH2 and SiO2-SH particles attached to microglia cells, 
while no interaction was detected with SiO2-PVP NPs (Figure 27). On a few occasions, 
highly fluorescent aggregates were seen intracellularly, however, the high 
autofluorescence of microglia cells, prevented to us to draw further conclusions. The 
location of nanoparticles could not be identified precisely with conventional confocal 
techniques, since the autofluorescence of cells masked the particle fluorescence. 
 
Figure 27: Interaction of SiO2 nanoparticles with microglia 
Purified cultures of microglia cells (A) strongly interact with plain SiO2 nanoparticles 
(B), while almost no interaction was detected with SiO2-PVP NPs (C). Cell cultures (in 
B and C) were exposed to silica NPs for 1-hour, in serum free conditions. Green: 
fluorescent NP; blue: bisbenzimide nuclear staining. 
Interaction of silica particles with progenitor cells was investigated on cultures of NE-4C 
neural stem cells. Particles were detected on the surface of NE-4C cells in cultures treated 
with SiO2, SiO2-NH2 and SiO2-SH particles, while no interaction was detected with SiO2-
PVP NPs (Figure 28). 
 
Figure 28: Interaction of SiO2 nanoparticles with NE-4C neural stem cells 
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NE-4C stem cells (A: non-treated) strongly interact with plain SiO2 nanoparticles (B), 
while almost no interaction was detected with SiO2-PVP NPs (C). Cell cultures (in B and 
C) were exposed to silica NPs for 1-hour, in serum free conditions. Green: fluorescent 
NP; blue: bisbenzimide nuclear staining. 
The in vitro cellular uptake experiments demonstrated that neurons, astrocytes and 
progenitor cells did not take up polystyrene or silica nanoparticles, although surface 
attachment of silica particles was visible on several occasions. 
The chemical composition of the surface of otherwise identical NPs importantly modified 
the biological interactions of particles. Regardless of the particle’s core material, 
“passivating” the particle surfaces with chemically inert polymers, like PEG or PVP, 
could significantly reduce the aggregation and cellular accumulation of particles. 
Among neural tissue-type cells, NPs were taken up readily by microglia cells known as 
the phagocytes of the brain. Experiments run at 37°C and 4°C demonstrated that 
nanoparticles did not accumulate inside cells at low temperatures indicating that particles 
were internalized through activity dependent cellular processes. 
While several conclusions could be drawn from fluorescence microscopic studies and 
confocal Z-stack analyses, the high cellular autofluorescence, together with the relatively 
weak particle fluorescence called for some more sensitive and more reliable detection 
method. 
5.3. Optimization of NP-detection by spectral imaging fluorescence microscopy 
Fluorescence microscopy is generally the method-of-choice in biomedical studies to 
localize specific biologically-relevant fluorescent materials, including nanoparticles 
(Bouccara et al. 2015). However, visualization of fluorescent NPs even with high-
resolution confocal microscopy has been notoriously difficult, because of their size 
(typically being between 1 and 100 nm) is below Abbe’s diffraction limit of ~ 250 nm. 
Moreover, the detection of fluorescent NPs is further hindered by the high 
autofluorescence intensity of biological samples (Bouccara et al. 2015), which does not 
allow visualization of individual particles or even small aggregates due to the low signal-
to-noise ratio. 
One of the objectives of my dissertation was to develop an imaging technique to study 
the tissue- and cell-type-specific distribution of fluorescent nanoparticles. To overcome 
the limitations caused by low NP fluorescence intensity and high tissue autofluorescence, 
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spectral imaging fluorescence microscopy was adapted. The basis of this technique is that 
the emitted light is detected separately on each wavelength throughout a defined spectrum 
range by using a multidetector array confocal arrangement. This acquisition approach 
combined with post hoc spectrum analysis allowed selective visualization and 
identification of nanoparticles in various cell cultures and tissue samples.  
5.3.1. Optimization of imaging 
Several excitation and detection wavelength combinations were probed, in order to find 
the optimal ranges for spectral identification of fluorochrome labelled nanoparticles. The 
highest signal-to-noise ratio for “yellow” particles was achieved by illuminating the 
sample at 457 nm excitation wavelength (Figure 29) and detecting the emitted light 
through a wavelength-range from 468 nm to 548 nm, with a spectral resolution of 2.5 nm. 
Optimal instrument settings for particles labelled with different fluorophores are shown 
in Table 3. 
 
Figure 29: Optimization of imaging 
Frequency of detected points (top row) and spectrum profiles (bottom row) of the same 
sample after excitation of “Yellow” NPs with 404nm, 457nm and 476nm laser lights. 
Detection wavelength ranged from 468 nm to 548 nm, spectral resolution: 2.5nm. Highest 
frequency of detected light points was reached when samples were excited at 457nm. 
404nm excitation has lower signal-to-noise ratio compared to the 457nm excitation, and 
has the disadvantage of exciting nuclear staining (DAPI) of cells. 
476nm excitation provides low signal-to-noise ratio, while it intermits with the detected 
spectra. This intermittence is due to the shielding of the detector from the laser light, 
which is marked with a blue arrow on the spectrum profile. 
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5.3.2. Spectra of nanoparticles used in experiments are stable 
With the optimized imaging settings, the fluorescence spectra of nanoparticles were 
investigated in various environments including PBS; PBS complemented with 1% bovine 
serum albumin; mounting medium (Mowiol); and within fixed tissue slices. The 
measured spectra of polystyrene nanoparticles showed parity with the spectrum provided 
by the manufacturer and did not vary substantially under different conditions (Figure 30). 
 
Figure 30: Spectra of “yellow” PS-NPs measured by spectral imaging fluorescence 
microscopy are stable in various environments 
Relative fluorescence intensity values are plotted throughout the detected spectrum 
range from 468 nm to 548 nm. NP-spectra in different conditions matches the reference 
emission spectrum provided by the manufacturer (aquamarine spectrum). 
Furthermore, particles with different surface compositions displayed identical 
fluorescence spectra, indicating that the functionalization had no direct effect on the NP 
fluorescence (Figure 31, Figure 32). 
 
Figure 31: Spectra of “yellow” PS-NPs after functionalization 
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Spectra of PS-COOH and PS-PEG was analyzed by spectral imaging fluorescence 
microscopy. Fluorescence intensities were plotted against and showed similarity to the 
reference emission spectrum provided by the manufacturer (aquamarine spectrum). 
 
Figure 32: Spectra of silica nanoparticles 
Spectra of bare SiO2-NP, SiO2-PVP, SiO2-NH3 and SiO2-SH was analyzed by spectral 
imaging fluorescence microscopy. Fluorescence intensities were plotted against and 
showed similarity to the reference emission spectrum provided by the manufacturer 
(green spectra). Red: autofluorescence of sample. 
For spectral analysis, an untreated (nanoparticle free) sample was used as negative 
control. Control spectra for each organ are shown in Figure 33, control spectra of cell 
cultures were determined similarly. 
Positive controls were also used throughout the study in order to identify nanoparticle 
derived fluorescence. For this reason, nanoparticles were seeded on control tissue 
sections, the fluorescence was determined and used as positive controls together with the 
spectra provided by the manufacturer. 
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Figure 33: Control spectra for in vivo measurements 
Spectral images showing the autofluorescence of non-treated brain (A), placenta (B), 
kidney (C) and spleen (D) sections used as negative controls in post hoc spectral 
identification of nanoparticles in tissues after in vivo NP-distribution. A’, B’, C’, D’: 
spectrum profiles of ROIs in the corresponding images. The spectrum of each ROI is 
marked with the same color as it is delineated in the microscopic image. Green curves 
represent fluorescence of “yellow” polystyrene nanoparticles (positive controls); red 
curve represents the spectrum of tissue autofluorescence (used as negative control later 
on). 
To quantitatively classify the NP-content of ROIs a spectral ratio (SR) was calculated 
from the relative fluorescence intensities at reference wavelengths. The reference 
wavelengths corresponeded to the intensity maximums of NP-fluorescence and the tissue 
autofluorescence. For samples containing “Yellow” polystyrene NPs the SR was 
calculated from the relative fluorescence intensities at 483nm and 528nm reference 
wavelengths (SRPS-NP = relative fluorescence intensity at 483 nm divided by the relative 
fluorescence intensity at 528 nm). For other particles see Table 3. ROIs were considered 
as NP-containing if the spectral ratio was above 1 (SR > 1). 
With the use of positive and negative spectral controls and spectral ratios, nanoparticles 
were reliably detected in various environments. Spectral imaging fluorescence 
microscopy proved to be a valuable tool to monitor fluorescent nanoparticles in samples 
where high autofluorescence is an issue. 
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Spectral fluorescence microscopy combined with confocal z-stack analyses could identify 
particle derived fluorescence intracellularly in microglia. The technique demonstrated 
that microglia cells internalized the plain SiO2, SiO2-NH2 and the SiO2-SH NPs, while 
SiO2-PVP particles were rarely found inside cells (Figure 34). 
 
Figure 34: Microglia cells internalize SiO2, SiO2-NH2 and SiO2-SH nanoparticles, 
but not SiO2-PVP 
Spectrum analyses was carried out on Z-stack optical slices of non-stained primary 
microglia cells to identify internalized silica nanoparticles. A: pristine SiO2-NP treated 
culture. B: SiO2-PVP treated culture. The spectrum of each ROI is marked with the same 
color as it is delineated in the microscopic image. Arrows in A mark the localization of 
ROI in the z-projection, showing intracellular localization. Lower panels: spectrum 
analysis confirms that the spectrum of the ROI is identical with particle derived 
fluorescence (SR > 1). Green curves represent particle fluorescence (positive controls, 
SR = 2,0); red curve represents autofluorescence of the non-treated culture (negative 
control: red curves SRred1 = 0,7; SRred2 = 0,5), SR for other ROIs in A: SRblue 1,8; SRpink 
1,7; SRyellow 2,0; SRaquamarine 2,0; SRorange 1,8; in B: SRblue/pink/yellow/aquamarine 0,6. 
5.4. In vivo distribution of polystyrene nanoparticles 
To determine how the molecular surface characteristics of otherwise identical polystyrene 
NPs could influence tissue penetration and accumulation, I applied optimized spectral 
imaging fluorescence microscopy technique on tracking particles coated with either 
carboxylated (PS-COOH) or PEGylated (PS-PEG) surfaces. 
Fluorescent PS-COOH or PS-PEG particles were suspended in PBS by sonication and 
administered via a single tail-vein injection into adult male (aged 25-30 days) or pregnant 
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female mice on the 10th to 15th post conception days. For evaluation of short-term and 
longer-term distribution of NPs, mice were sacrificed either 5 minutes (nPS-COOH = 3; nPS-
PEG = 3), or after a 4-day long survival period (nPS-COOH = 3; nPS-PEG = 3). The anatomical 
distribution of PS-NPs in various organs were determined by fluorescence spectrum 
analysis (Figure 35). 
 
Figure 35: Experimental design and fluorescence spectrum analysis of tissue 
samples of NP-treated mice 
Carboxylated or PEGylated particles were administered to mice through a single tail vein 
injection. After 5-minutes or 4-days exposure distribution of NPs was evaluated by 
fluorescent spectrum analysis. Spectrum of selected regions in tissue slices from treated 
mice were compared to the autofluorescence of non-treated tissues (red curve, negative 
control) and to the fluorescence of NPs (green curve, positive control) by calculating the 
SR at 483 and 528 nm. ROIs were considered NP-containing if SR > 1. 
Intravenous injection of PS-COOH or PS-PEG nanoparticles at a blood-concentration of 
33.3 µg/ml did not cause circulatory blockage or other life threatening condition. 
The organs studied in details including the brain, kidney, liver, placenta and the spleen 
contained different amounts of nanoparticles, and displayed distinct extent of clearing 
after the 4-day post-injection period (Table 6). 
Table 6: Presence of polystyrene nanoparticles after intravenous injection 
Organs were excised 5 minutes or 4 days after the particles were administered into the 
tail vein. 
 Brain Placenta Kidney Liver Spleen 
Embryonic 
tissue 
PS-COOH 
5 min + + + + + - 
4 days - - - + + - 
PS-PEG 
5 min - - + + + - 
4 days - - + + + - 
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Five minutes after nanoparticle injection, high abundance of both PS-COOH and PS-PEG 
NPs were found within the kidney, liver and the spleen known to be responsible for 
elimination of toxic products from the body. In the brain and the placenta protected by 
physiological barriers, only PS-COOH NPs were deposited, and PS-PEG NPs were rarely 
found (Table 6). 
In the brain, aggregated PS-COOH particles were concentrated in large vessels and 
capillaries, whereas the parenchyma was largely devoid of NPs (Figure 36 A-A’, Figure 
37). The attachment to vessel walls was restricted to short-term exposure, PS-COOH NPs 
completely cleared out from the brain in four days after nanoparticle administration 
(Figure 36 C-C’). In accord with the in vitro experiments, PEGylation reduced the 
interaction of NPs with the environment, including the attachment to vessel walls (Figure 
36 B-B’ and D-D’, Figure 37). 
 
 
Figure 36: Distribution of PS-NP in the brain after systemic exposure 
Spectral images of tissue sections from the mouse brain 5 minutes (A, B) and 4 days (C, 
D) after injection of PS-COOH (A, C) or PS-PEG (B, D) nanoparticles into the tail vein. 
A’, B’, C’, D’: spectrum profiles of ROIs in the corresponding images. 
Spectrum analysis proves the presence of PS-COOH NPs in brain vessels 5 minutes after 
exposure (A’) and indicates their clearance after 4 days (C’). PS-PEG particles did not 
attach to vessel walls (B-B’ and D-D’). The spectrum of each ROI is marked with the 
same color as it is delineated in the microscopic image. Green curves represent particle 
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fluorescence (positive controls, SR = 1,9); red curve represents tissue autofluorescence 
(negative control; SR = 0,6). SR for ROIs in A: yellow-1,5; pink-1,3; orange-1,3; blue-
1,2; aquamarine-1,6; SR of ROIs in B-C-D were between 0,5 and 0,7. 
 
Figure 37: Polystyrene NPs in brain vessels 
Fluorescence images of sections made from the forebrain of PS-PEG (A) or PS-COOH 
(B) injected adult mice. Animals were sacrificed 5 minutes after intravenous injection. 
Sections were stained for Claudin V (red); cell nuclei are shown in blue. Scale bars: 
50 µm 
Spectrum analysis proved the presence of PS-COOH NPs in brain vessels 5 minutes after 
exposure and indicated an almost complete clearance after 4 days. PS-PEG particles did 
not attach to vessel walls even 5 minutes after administration. 
In the placenta, PS-COOH NPs, but not PS-PEG NPs were seen in the lacunas (Figure 
38), and importantly, neither type of nanoparticles was found in embryonic tissues (Figure 
39), indicating a proper placental barrier function. As in the brain, both types of particles 
cleared out completely from the placenta within 4 days (Figure 38). 
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Figure 38: Distribution of PS-NPs in the placenta 
Spectral images of tissue sections from placenta 5 minutes (A, B) and 4 days (C, D) after 
injection of PS-COOH (A, C) or PS-PEG (B, D) nanoparticles into pregnant female mice. 
A’, B’, C’, D’: spectrum profiles of ROIs in the corresponding images. 
Spectrum analysis shows PS-COOH particles in the lacunas of placenta 5 minutes after 
exposure (A’) and indicates clearance after 4 days (C’). The spectrum of each ROI is 
marked with the same color as it is delineated in the microscopic image. Green curves 
represent particle fluorescence (positive controls, SR = 1,9); red curve represents tissue 
autofluorescence (negative control, SR = 0,6). SR for ROIs in A: yellow-1,8; pink-2,0; 
orange-2,0; blue-1,8; SR of ROIs in B-C-D were under 0,6. 
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Figure 39: Embryonic tissues were free from nanoparticles 5 minutes after maternal 
NP-administration 
Sections were made from mouse embryonic (E 15) forebrain cortex (A, B, C) and liver 
(D, E) 5 minutes after the injection of carboxylated PS-NP into the tail vein of the mother. 
Cell nuclei were stained with bisbenzimide (blue). Representative spectrum images (C, 
E) and spectrum profiles (C’, E’) showed no particles in the embryonic brain or liver 
tissues (SRROI < 1). Scale bars: 50 µm. 
In striking contrast to the brain and the placenta, both PS-COOH and PS-PEG NPs were 
present in the kidney 5 minutes after nanoparticles administration. Particles were found 
in the glomeruli and also in the interstitium around the tubuli (Figure 40 A-A’ and C-C’). 
Four days later, PS-COOH NPs cleared from the kidney, while a few PS-PEG NPs were 
still stuck within the glomeruli (Figure 40 B-B’ and D-D’). 
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Figure 40: Distribution and accumulation of polystyrene nanoparticles in the kidney 
Spectral images of adult mouse kidney sections 5 minutes (A, C) and 4 days (B, D) after 
injection of PS-COOH (A, B) or PS-PEG (C, D) nanoparticles through the tail vein. A’, 
B’, C’, D’: spectrum profiles of ROIs in the corresponding images. The spectrum of each 
ROI is marked with the same color as it is delineated in the microscopic image. Green 
curves represent particle fluorescence (positive controls, SR = 1,9); red curve represents 
tissue autofluorescence (negative control, SR = 0,5). SR for ROIs in (A): yellow-2,0; 
purple-2,2; blue-1,8; orange-1,5; (B): yellow-0,5; pink-0,4; blue-0,3; (C): yellow-1,6; 
pink-1,1; blue-1,6; (D): yellow-2,3; pink-1,8; blue-1,6. 
In the liver, high densities of both NPs were found regardless of the functionalization, 
and PS-COOH and PS-PEG NPs were detected even after 4-day survival. The abundance 
of particles was clearly seen with traditional fluorescence microscopy (Figure 41). 
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Figure 41: PS-NPs accumulate in the liver 
Traditional fluorescence microscopic images of liver sections of non-treated (A) and NP-
injected (B, C, D) adult mice. Animals were sacrificed 5 minutes (B) and 4 days (C) after 
intravenous injection of PS-COOH NPs and 4 days after injection of PS-PEG (D) NPs. 
Green: fluorescent PS-NP; blue: bisbenzimide nuclear staining in blue.  
In the spleen, nanoparticles with both functional groups were identified in high densities 
(Figure 42). In 5-minute exposure, NPs were mainly restricted to the marginal zone, 
which is a region enriched in monocytes/macrophages (Bronte and Pittet 2013). 
Colocalization analysis directly demonstrated the presence of both NPs within the Iba-1 
immunopositive phagocytic cells (Figure 43). 
After 4 days, a characteristic redistribution of particles was detected regardless of 
functionalization. NPs with both functional groups were identified in the white pulp 
(Figure 42, red arrows). 
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Figure 42: Distribution and accumulation of PS nanoparticles in the spleen 
Spectral images of mouse spleen sections after a single intravenous injection of 
carboxylated (A, B) or PEGylated (C, D) polystyrene nanoparticles, 5 minutes (A, C) and 
4 days (B, D) after exposure. Red arrows indicate translocated particles to the white pulp 
during the 4-day after exposure period. A’, B’, C’, D’: spectrum profiles of ROIs in the 
corresponding images. The spectrum of each ROI is marked with the same color as it is 
delineated in the microscopic image. Green curves represent particle fluorescence 
(positive controls, SR = 2,0); red curves represent tissue autofluorescence (negative 
controls, SR1 = 0,4; SR2 = 0,5). SR for ROIs in A-B-C-D were above 1,2. 
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Figure 43: PS-NPs are associated with monocytes/macrophages, identified by Iba-1 
staining 
A-C: Immunohistochemical staining of spleen macrophages, with anti-Iba-1 antibody (A; 
red), and visualization of carboxylated PS-NPs (B; green) 4 days after a single 
intravenous injection of nanoparticles. Merged image (C) shows that nanoparticles 
(green) are co-localized with the Iba-positivity of marginal zone macrophages (red). 
D-F: Confocal images of spleen sections from non-treated (D) or PS-PEG-injected (E, F) 
mice. Samples were collected 5 minutes (E) or 4 days (F) after exposure to PS-PEG, and 
were stained for Iba-1. The sample from non-treated animal (D) serves also as staining 
control. Enlarged areas of the boxed regions in E and F, show the presence of PS-PEG 
NPs in Iba-1 positive phagocytotic cells. G: The spectra of ROIs indicated the presence 
of PS-PEG NPs on images of both, 5-min (blue and turquoise ROI) and 4-day (yellow 
and pink ROI) samples. The spectrum of each ROI is marked with the same color as it is 
delineated in the microscopic image. Fluorescence spectrum of ROIs were compared 
against spectrum of non-treated sample (autofluorescence, red curve, SR = 0,3) and 
particle fluorescence (positive controls, green curves, SR = 1,9). SR of ROIs: blue-1,4; 
turquoise-1,3; yellow-1,7; pink-1,7. 
Taken together, spectral imaging fluorescence microscopy was instrumental in 
characterizing the extent of polystyrene nanoparticle penetration into different organs. 
The proper barrier-functions of the blood-brain-barrier and the placenta prevented the 
penetration of nanoparticles into the brain parenchyma and embryonic tissues, 
respectively. PS-COOH NPs attached to vessel walls, while PEGylation proved to be 
enough to prevent particles from adhering to the vascular endothelium. On the other hand, 
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in organs which are responsible for detoxication of the body, as the kidney, liver and the 
spleen, significant amounts of PS-NPs were accumulated, and this accumulation was not 
prevented by PEGylation.  
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6. DISCUSSION 
As the biological behavior of nanoparticles is influenced by multiple factors (Nel et al. 
2009), one of the key elements of nanomaterial related research is the thorough 
characterization of the particles. The comprehensive knowledge on the properties of NPs 
(naïve NPs or NPs modified by the experimental milieu) is crucial to understand and 
interpret biological results. 
My thesis research was focused on the impacts of chemical surface-compositions on the 
biological interactions of nanoparticles. To dissect the effects, nanoparticles with uniform 
size and shape but with different chemical surface compositions were used throughout 
the experiments. Polystyrene and silica was chosen as the core material of NPs, because 
of their stability in biological solutions, and because ions or toxic compounds could not 
dissolve from them (Cohen et al. 2002, Food and Drug Administration 2013). 
Polystyrene nanoparticles were functionalized with carboxyl- or PEG-functional groups, 
while silica nanoparticles were either left unmodified (SiO2-NP) or functionalized with 
amino-, mercapto- or PVP functionalities (SiO2-NH2, SiO2-SH, SiO2-PVP). As expected, 
surface-coating resulted in significantly different zeta-potential of NPs, ranging from 
strongly negative to positive values. Physicochemical characterization of PS- and SiO2-
NPs revealed that the size, shape and the fluorescence spectra of the emitted light of NPs 
were not disturbed by surface functionalization. 
Besides core material, size, shape, and surface composition the biological distribution of 
NPs is highly influenced by substances adsorbed on NP surfaces, (Nel et al. 2009). Due 
to the highly reactive surfaces, nanoparticles attach to and adsorb chemical substances 
from the surrounding environment (Casals et al. 2010, Monopoli et al. 2012). The 
composition and thickness of adsorbed layers (the so-called corona) depends on the 
chemical properties of both the NP surface and the environment (Casals et al. 2011, 
Lundqvist et al. 2011, Casals and Puntes 2012). The corona governs the interaction of 
NPs with biological structures, hence it plays a decisive role in the tissue- and cell-type-
specific NP distribution (Salvati et al. 2013, Tenzer et al. 2013). By changing the chemical 
reactivity of NP-surfaces, for example by coating the particles with „passivating” 
functional groups (Peracchia et al. 1999b, Sacchetti et al. 2013), the composition of the 
adsorbed corona can be altered both quantitatively and qualitatively. Our own 
electrophoresis data confirmed that PEGylation could not only reduce aggregation in 
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organic solutions, but could also scale down the amount of adsorbed proteins on particles. 
Similar results were shown for PVP-coated silica nanoparticles incubated in 10% FCS-
MEM (Izak-Nau et al. 2013a, 2013b). 
 
We showed previously, that neither of the investigated particles displayed toxic effects 
on cells exposed to particles in vitro up to concentrations of 1011 NPs/ml (Izak-Nau et al. 
2013a, Murali et al. 2015). In in vitro uptake experiments, incubation with 3.5 x 1010 to 5 
x 1011 NPs/ml polystyrene or silica nanoparticles in serum free conditions did not result 
in obvious structural damage to cells. Cell viability (MTT-reduction assay) and 
membrane integrity (LDH-release assay) tests confirmed, that polystyrene or silica NPs 
are not toxic for the investigated neural cell types (Izak-Nau et al. 2013a, Murali et al. 
2015). Mild toxicity was detected only at extremely high concentrations (1012 - 1013 
particles/ml), which is 100 times higher that we used in the presented in vitro experiments. 
The variations in the mild in vitro effects correlated with the chemical surface 
composition of particles. Amine functionalization of SiO2 NPs increased, while PVP 
coating reduced the particle toxicity (Izak-Nau et al. 2013a). Similarly, carboxylated PS 
NPs showed slightly but significantly increased cellular effects in comparison to PEG 
coated particles (Murali et al. 2015). The data of my thesis work demonstrated that 
nanoparticles with PEG- or PVP-coated surfaces displayed markedly different in vitro 
and in vivo distribution compared to particles with non-passivated, ionic surface groups 
(Kenesei et al. 2016). 
 
Fluorescence microscopy is generally the method-of-choice in biomedical studies to 
monitor fluorescent materials, including nanoparticles (Bouccara et al. 2015) at the tissue 
and cellular levels. However, visualization of fluorescent NPs even with high-resolution 
confocal microscopy has been notoriously difficult, because the size of NPs is below 
Abbe’s diffraction limit. Therefore, fluorescent NPs can only be detected if they passively 
aggregate in the cellular media or at biological interfaces (e.g. on the blood vessel wall or 
on the cell surface) (Gambinossi et al. 2014), or if they are actively taken up by cells and 
are concentrated into endocytotic vesicles or lysosomes (Al-Rawi et al. 2011, Firdessa et 
al. 2014, Murugan et al. 2015). In serum free conditions PS-COOH, SiO2, SiO2-NH2 and 
SiO2-SH nanoparticles formed light microscopically detectable agglomerates, which 
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settled on and attached to cell surfaces. In agreement with the DLS data on reduced 
agglomeration and reduced protein adsorption, PVP- and PEG-functionalized NPs did not 
form such detectable agglomerates on cell surfaces. 
Cellular uptake of nanoparticles depended on functional groups, and was less related to 
the core material. The internalization of nanoparticles with hydrophilic, strongly charged 
functional groups, like PS-COOH, SiO2, SiO2-NH2 and SiO2-SH was markedly higher, 
compared to the hydrophobic and neutral PVP- and PEG-functionalized particles. While 
cell surface attachment of silica particles was more pronounced, than that of PS-NPs; 
important in vitro internalization of particles was observed only in cultures of the 
phagocytic microglia cells. Astrocytes which are also known to phagocytose smaller cell 
debris from their environment (Sokolowski and Mandell 2011) were occasionally labelled 
by silica NPs, but confocal z-stack imaging showed surface attachment of particles 
without internalization. Importantly, neural stem cells and neurons, including neurons 
differentiated from stem cells in vitro, and those isolated from the mouse forebrain and 
cultured in primary cultures did not take up any of the particles. 
The surface attached particle aggregates in cell cultures could be formed by spontaneous 
particle aggregation, as shown in cell-free aggregation experiments. The intracellularly 
localized particle aggregates in microglia, however, suggested, that nanoparticles were 
internalized through active cellular processes, like phagocytosis and pinocytosis, and 
were collected in endocytotic vesicles, phagosomes or lysosomes. To test whether 
intracellular accumulation was a result of active cellular uptake, primary brain cell 
cultures were exposed to nanoparticles at 4°C and compared to cultures treated at 
physiological 37°C. The reduced accumulation of NPs at 4°C indicated that the microglial 
NP uptake is a temperature- and activity-dependent process. The results were in 
accordance with recent publications showing that medium-sized (20nm< x >100nm) PS-
NPs can be internalized by multiple energy-dependent processes, including 
macropinocytosis, phagocytosis, clathrin-mediated endocytosis, caveolae-mediated 
endocytosis, and clathrin- and caveolae-independent pathways, which can collect NPs in 
acidic vesicles through the endolysosomal pathway (Firdessa et al. 2014). These vesicles 
display high autofluorescence. Therefore, the identification of fluorescent particles in 
such vesicles could be achieved only by distinguishing particle fluorescence from the 
light emitted by the vesicle material. Fluorescence spectrum analyses together with 
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temperature-dependent uptake experiments demonstrated that in vitro, ~ 50 nm silica or 
polystyrene NPs were actively internalized only by “professional” phagocytes. 
 
The in vivo distribution of differently functionalized polystyrene nanoparticles, namely 
PS-COOH NPs, representing strong negative surface charge, and PS-PEG particles with 
hydrophilic and charge-neutralizing -PEG chains, were assessed in mice after a single 
intravenous injection. The use of particles in the ~50 nm size range promised several 
advantages. Particles were comparable in size with natural assemblies of protein 
complexes, but were big enough not to be excreted rapidly by the kidney, which is known 
to retain proteins and particles larger than 10 nm (Choi et al. 2007).  
The single tail-vein injection equaled to a blood-concentration of 33.3 µg/ml 
nanoparticles, which corresponds to 1.2 x 1011 NPs/ml blood. This concentration is 10 
times lower, than the concentration where mild toxicity was observed on cultured neural 
cells (Murali et al. 2015). Additionally, PS-COOH and PS-PEG particles were expected 
not to impaire the blood flow conditions at the time of injection. According to in vitro 
results, large-scale aggregate formation, which could block circulation, was not expected. 
In the experiments, intravenous injection of 1.2 x 1011 NPs/ml PS-COOH or PS-PEG 
nanoparticles did not cause life circulatory blockage or other life threatening conditions 
in mice. 
 
Several imaging approaches have already been used to visualize nanoparticles in vivo 
(Ostrowski et al. 2015). Some studies investigated NP distribution at the whole-body level 
by using magnetic resonance imaging, computed tomography, positron emission 
tomography, or radiolabeling techniques (Choi et al. 2007, Leary and Key 2014, Liu et 
al. 2014); whereas other reports focused on the subcellular localization of NPs by 
exploiting transmission or scanning electron microscopy (Fagerland et al. 2012, Ye et al. 
2015). Relatively few studies attempted to follow the in vivo distribution of distinct types 
of NPs at the tissue and cellular levels (Cho et al. 2009, Liu et al. 2014, Liba et al. 2016). 
This approach would be important from a medical perspective, because specific tissues 
and cells may be differentially involved in pathophysiological responses to nanoparticle 
exposure. Yet the availability of high-throughput imaging modalities to compare the 
distribution of different NPs in the living body, is rather limited. 
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The small size of NPs, which is below the resolution of diffraction limited systems, makes 
the detection of fluorescent NPs in biological samples challenging. Fluorescent NP-
detection is further hindered by the high autofluorescence of biological samples, which 
does not allow visualizing small and scattered particles due to the low signal-to-noise 
ratio (Bouccara et al. 2015). Increasing fluorescent dye concentration on the NP surface 
may lead to enhanced cytotoxicity; therefore, interest was turned to polymer nanoparticles 
which encapsulate fluorescent dyes. While the covalent embedding of the dye into the 
core-material prevents dissolution, the amount of “in-core” dye is limited (Hu and Gao 
2010, Naczynski et al. 2010) and hinders the fluorescence detection. 
These constraints stressed the importance of applying new imaging approaches in the 
studies on tissue- and cell-type-specific NP distribution of fluorescent NPs, and prompted 
us to adapt spectral imaging fluorescence microscopy, with the aim to overcome the 
limitations caused by low NP fluorescence versus high tissue autofluorescence. The high-
resolution of confocal microscopy combined with spectral acquisition and post hoc 
spectrum analysis enabled more detailed regional and cellular analysis of nanoparticles 
in various tissues. 
 
For evaluation of short-term and longer-term distribution of NPs, mice were sacrificed 
either 5 minutes, or after a 4-day long survival period. Initial distribution of particles 
could not be revealed by histological methods because of the high heart rate (300-800 
beats/min) and 20-45 µl stroke volume of mice resulting in an average 20 ml/min cardiac 
output (Janssen et al. 2002). The 5 min exposure allowed investigating short-term tissue 
distribution of particles after a single injection and comparison to a longer term (4 day) 
distribution. 
Five minutes after NP-injection, significantly more PS-COOH then PS-PEG particles 
were found at the walls of brain vessels and in the placenta. As it was expected from prior 
experiments and from literature data (Peracchia et al. 1999a, Chilukuri et al. 2008), 
PEGylation inhibited the attachment of particles to biological interfaces and kept particles 
longer in the circulation. On the other hand, PS-COOH particles could interact with vessel 
walls and cell surfaces and were detected in both the brain vessels and the placenta. 
However, particles were never found in the brain parenchyma or in embryonic tissues, 
indicating a proper barrier function of the blood-brain barrier and the placenta against PS-
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NP, as it was shown also in ex vivo human placental perfusion model (Grafmueller et al. 
2015). 
As opposed to in vitro uptake experiments, PEGylation could not prevent the in vivo 
uptake of PS-PEG NPs by professional macrophages (Moghimi et al. 1991, Moros et al. 
2012). We found a remarkable accumulation of both PS-COOH and PS-PEG 
nanoparticles in the kidney, liver and the spleen, e.g. in organs responsible for elimination 
of particulate polluting agents from the circulation. The apparent controversy between the 
in vitro and in vivo uptake of PEGylated PS-NPs by macrophages may be explained by 
two conditions: 
i) in vitro uptake took place in serum-free conditions, where the adsorbed corona 
layers of PEGylated particles are substantially different from those formed in vivo, 
in the blood circulation; 
ii) The in vitro investigated microglia cells exist in different activation-state in 
comparison to in vivo macrophages. This later assumption is supported by our 
earlier findings (Murali et al. 2015) that cyto-active substances as 
lipopolysaccharides built on the surface of PS-PEG NPs destroys the attachment-
reducing effect of PEGylation. 
After 4 days, the particles were completely cleared from the vessels of the brain and the 
placenta, but were accumulated in the liver and the spleen. The persisting presence of PS-
PEG particles in the glomeruli, suggested that particles were accumulated by 
intraglomerular mesangial cells known to phagocytose contaminating particles, 
mesangial matrix material and cell debris (Schlöndorff and Banas 2009). In the spleen, 
several particles were translocated from the marginal zones into the white pulp during the 
4-day post-injection period. The observations on the storage and translocation of these 
nanoparticles are worthy of further consideration, since they may suggest a route for 
antigen presentation. As particles surfaces can adsorb multiple compounds, including 
toxins (Murali et al. 2015) and compounds of decaying cells, several particle-carried 
material can be presented by spleen macrophages to the lymphocytes of the white pulp 
(Bronte and Pittet 2013) and on that way adaptive immune responses can be initiated. 
Regarding the above considerations, the inflammation-initiating effects of otherwise 
“harmless” NPs should not be neglected. 
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The observations indicate that medium-sized (50-90 nm) non-biodegradable 
nanoparticles which are captured by macrophages in the spleen and the liver or even in 
the kidney interstitium, cannot be easily removed from the body. Regarding the fact that 
material of dying cells will be ingested by neighboring phagocytes, the question can be 
raised whether such particles can be cleared at all. Long-term accumulation and limited 
clearance may cause problems if repeated nanoparticle loading is considered, even if the 
acute single dose of potentially “harmless” particles is low. 
For studies on particle penetration and long-term tissue-residence, spectral imaging 
fluorescence microscopy may provide methods which can monitor the distribution and 
accumulation of fluorescently labeled NPs. The results demonstrate that carefully 
controlled fluorescence sprctrum analysis can find NPs in various tissues with high 
accuracy and in a time-frame which cannot be achieved with electron microscopy.  
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7. CONCLUSIONS 
The results of my thesis work led to the following conclusions on the altered 
characteristics, cellular uptake and in vivo distribution of differently functionalized 
polymer nanoparticles: 
 The cellular uptake and biodistribution of NPs is essentially modified by the 
chemical composition of the NP’s surface. 
 Passivating the NP surfaces with PEGylation or PVP-coating reduces the amount 
of proteins adhered to particles, alters the protein corona composition, scales 
down the aggregation in organic solutions and inhibits the interactions with the 
environment, including biomolecules and cells. 
 Cellular interactions of NPs are highly dependent on the types of cells and the 
surface characteristics of NPs: 
o Neurons and neural stem cells did not take up ~50 nm silica or PS NPs in 
vitro. 
o In astrocyte enriched primary cultures, GFAP positive astrocytes did not 
internalize silica or PS NPs, even if strong attachment of charged silica 
NPs to cell surfaces was observed. The phenomenon was reduced by 
PEGylation or PVP-coating of the particles. 
o Microglia cells internalize significant amounts of silica and PS-NP by 
energy-dependent endocytic mechanisms, while PEGylation and PVP-
coating markedly reduced the process. 
 Chemical properties of the nanoparticle surfaces interfere with the in vivo fate of 
PS particles including short-term invasion and longer-term accumulation: 
o Initial attachment to blood vessel walls is reduced by PEGylation. 
o Barrier functions of the blood-brain-barrier and the placenta completely 
prevents the penetration of particles into the brain parenchyma and 
embryonic tissues, respectively. 
o Particles with carboxylated or PEGylated surface functionalizations were 
retained in the reticuloendothelial organs. Strong accumulation of PS-
COOH and PS-PEG was detected in the liver, in the macrophages of the 
spleen marginal zones, and some particles were found also in the 
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intraglomerular mesangium of the kidney. The accumulation and long-
term storage of nanoparticles in the reticuloendothelial systems rise 
important questions on the long-term health-risk even of otherwise non-
toxic particles. 
 Spectral imaging fluorescence microscopy allowed detecting the tissue- and cell-
type-specific accumulation of fluorescent polymer nanoparticles in a time-frame 
which cannot be achieved with electron microscopy. The method was 
instrumental in the analysis of in vivo distribution of PS-NP, where the high 
autofluorescence of native tissues hinders the identification of particle 
fluorescence. 
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8. SUMMARY 
In the present work the physicochemical characteristics and biological interactions of 
polymer nanoparticles were investigated, including in vitro cellular uptake and 
distribution in mouse tissues after a single intravenous NP-injection. During my 
dissertation work, I assessed the influence of the chemical composition of particle 
surfaces on the interaction of NPs with biological material. 
The much larger proportion of surface-exposed atoms in nanoparticles provides unique 
properties compared to bulk materials, including enhanced chemical reactivity and large 
surface-energy. “Passivating” the surfaces of silica and polystyrene NPs with PEG- or 
PVP polymers, the reactivity of particles was decreased resulting in reduced aggregation 
and protein corona formation. 
Experiments on the uptake of functionalized NPs by cultured neural stem- and tissue-type 
cells showed marked differences depending on both, the particle surface characteristics 
and the types of interacting cells. Particles with charged surface groups were taken up 
actively by microglia cells in vitro; while passivated NPs hardly interacted with 
phagocytic cells. 
During the dissertation work my aim was to establish an imaging approach, which allows 
visualizing fluorescent NPs in various tissues. The detection of fluorescent NPs is 
hindered by their small size, which is below the resolution of diffraction limited systems, 
and by the high autofluorescence of biological samples. To overcome the limitations 
caused by high autofluorescence and low particle fluorescence, spectral imaging 
fluorescence microscopy was used. Spectral image acquisition combined with post hoc 
spectrum analysis could reliably detect fluorescent NPs in biological samples at the 
tissue- and cellular level. 
With the established method I assessed the biodistribution and accumulation of NPs after 
a single intravenous injection in mice. Our in vivo NP-exposure data draws attention to a 
largescale and charge-independent accumulation of NPs in the reticuloendothelial organs. 
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9. ÖSSZEFOGLALÁS 
Doktori munkám során fluorescens polimer nanopartikulumok fizikokémiai 
tulajdonságait és biológiai hatásait vizsgáltam, különös tekintettel a NP-ok sejtes 
internalizációra in vitro körülmények között, valamint egér szövetekben intravénás 
adminisztrációt követően. Munkám során arra kerestem a választ, hogy miképp 
változtatják meg a felszíni töltést befolyásoló funkciós csoportok a NP-ok biológiai 
viselkedését. 
A NP-ok kivételes tulajdonságai kis méretükből és nagy fajlagos felületükből fakadnak, 
melynek következtében sokkal több atom helyezkedik el a struktúra felszínén a 
makroméretű részecskékhez képest. A felszíni atomok reakcióképessége nagyobb, 
változásuk a NP felszíni energiájára jelentős hatással van. Eredményeink szerint a 
passziváló PEG- vagy PVP-csoporttal funkcionalizált szilika és polisztirol NP-ok 
kevesebb kölcsönhatást alakítanak ki a környezettel, mint a töltéssel rendelkezők; 
valamint a passzivált felszínű NP-ok felszínén kialakuló protein korona is eltérő. 
Munkám során vizsgáltam, hogyan befolyásolják a NP-ok felszíni töltését befolyásoló 
(pozitív-, negatív töltést eredményező vagy passziváló) funkciós csoportok a NP-ok sejtes 
internalizációját. Megfigyeléseink szerint a partikulum-felvétel erősen függ mind a NP-
felszín kémiai összetételétől, mind a kölcsönható sejt típusától. Idegszöveti sejtek 
tenyészeteiben a mikroglia sejtek aktív fagocitózissal internalizálták a részecskéket, mely 
folyamat a NP felszín passziválásával jelentősen csökkenthető volt. 
Doktori munkám további részében célom egy olyan képalkotó eljárás kidolgozása volt, 
mellyel fluoreszcens NP-ok sejtes felvétele vizsgálható változatos szövet mintákban. A 
NP-ok detektálását nehezíti kis méretük, mely a diffrakció által limitált mikroszkópos 
rendszerek felbontóképessége alatt marad, valamint a biológiai minták magas 
autofluoreszcenciája. A magas szöveti autofluoreszcencia és az alacsony NP-
fluoreszcencia okozta detekciós korlátok leküzdésére spektrális képalkotású fluorescens 
mikroszkópiát alkalmaztam, mely post hoc spektrum analízissel kombinálva 
megbízhatóan detektálta a fluoreszcens NP-okat biológiai mintákban. A módszerrel 
polisztirol NP-ok in vivo eloszlását és hosszabb távú felhalmozódását vizsgáltam 
intravénás NP-adminisztrációt követően egerekben. Kapott eredményeink a 
retikuloendoteliális rendszerben végbemenő nagymértékű, töltéstől független NP-
felhalmozódásra hívják fel a figyelmet.  
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